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The pulmonary rehabilitation programme is an evidence-based intervention to treat and manage 
people living with long-term breathing conditions, mainly chronic obstructive pulmonary disease 
(COPD). Pulmonary rehabilitation is a structured eight-week long programme, which requires 
participants to attend the programme twice a week, for two hours each session. The two-hour session 
is broken down to one hour of exercise and one hour of education. The literature suggests that the 
pulmonary rehabilitation is useful in improving self-management skills, improving fitness levels, and 
reducing social isolation to the people living with chronic respiratory illnesses. Despite the strong 
evidence behind pulmonary rehabilitation, the programme is still not well utilised by health 
professionals and people living with chronic respiratory illnesses. There are many reasons for not 
participating in a pulmonary rehabilitation programme, such as not understanding the content of 
pulmonary rehabilitation, transportation difficulties, or work commitments. This study helped the 
pulmonary rehabilitation governance group to explore a different delivery model and evaluate the 
effect of this alternative pulmonary rehabilitation delivery model: the home-based pulmonary 
rehabilitation. 
Participants (n= 21, 11 males: 10 females, mean age of 68.76 years, 71% of the participants identified 
themselves as New Zealand European and 14% identified as Māori) were recruited from the existing 
pool of withdraw referrals, that is people who had been referred to the programme but never attended 
or completed a programme. These participants had been offered pulmonary rehabilitation in the past 
but either declined or had been unable to participate in a programme. All the participants received a 
home visit from the physiotherapist for assessments, education, and to set up the DVD exercise 
regime. The home-based programme lasted for eight weeks and each participant received a weekly 
telephone call from a health professional to check on the participant’s exercise progress. The Chronic 
Respiratory Questionnaire (CRQ), COPD Assessment Tool Score (CATS) and EQ-5D questionnaires 
were used to evaluate the quality of life and self-management before and after the home-based 
programme. The Hospital Anxiety and Depression Scale (HADS) was used to assess participants’ 
psychological wellbeing. Finally, one-minute sit-to-stand tests were carried out before and after the 
programme to identify any change in the participant’s exercise tolerance. The collected data were 
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analysed and compared to the control, centre-based pulmonary rehabilitation data, using a 2-tail t-test 
to determine statistical significant difference.  
The home-based pulmonary rehabilitation programme performed no worse than the gold standard 
centre-based pulmonary rehabilitation in the majority of the outcome measures used. The home-based 
pulmonary rehabilitation was better at reaching out to younger, male, and Māori participants when 
compared to the control, the centre-based pulmonary rehabilitation. The majority of the 
primary and secondary outcome measures showed that the home-based pulmonary 
rehabilitation performed as well as the control, the centre-based pulmonary rehabilitation 
programme, in making significant improvements. But in fatigue management, exercise 
tolerance, and EQ-5D, the control, centre based group was able to achieve superior outcomes 
when compared to the home-based pulmonary rehabilitation. 
This study has successfully demonstrated that the home-based pulmonary rehabilitation is an 
effective alternative to the gold standard centre-based pulmonary rehabilitation when 
managing people living with COPD. Despite the fact that the home based group participants 
were recruited from a less favourable pool of participants, the withdrawals, the home-based 
pulmonary rehabilitation was an enabler to positive and significant improvement to the 
participants in all outcome measures. The main weaknesses of the home-based pulmonary 
rehabilitation lies with the reduced clinician supervision of the participant’s exercise regime 
and the lack of social interaction in this delivery model. The author believes, however, that 
with continuous service review, research and development, these weaknesses can eventually 
be effectively managed and minimised.  
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Chapter 1:   Introduction  
Introduction- a classic Chronic Obstructive Pulmonary Disease patient scenario 
 
Jason is a 60 year old semi-retired beef farmer living in Darfield. Five years ago, he 
started noticing a gradual increase in his level of shortness of breath while he was 
working on the farm. He was still a cigarette smoker (15 cigarettes a day) at the time and 
had been a smoker for the last 45 years. Two years ago, he was diagnosed with chronic 
obstructive pulmonary disease (COPD) through a breathing test known as spirometry. 
Jason has a good relationship with his General Practitioner (GP). He was very keen to 
learn more about this newly diagnosed medical condition and discover ways to improve 
his breathlessness. Jason discussed his breathlessness concerns with the GP and as a 
result of the discussion, the GP referred Jason to the Community Pulmonary 
Rehabilitation Service. The Community Pulmonary Rehabilitation team contacted Jason 
but, due to his work commitments and rural residence, Jason was not able to attend a 
programme. A clinic letter was generated to inform the GP that this Pulmonary 
Rehabilitation referral was closed for now due to Jason’s unavailability.  
The above story is a classic scenario that the Community Pulmonary Rehabilitation team 
faces on a weekly basis. And to date, there is no clear pathway or alternative service that the 
team could offer to people like Jason who are younger, still working and newly diagnosed 
with COPD. For this reason a solution for COPD patients like Jason needed to be identified 
and implemented, and this is the topic of the thesis. 
What is COPD? 
Chronic obstructive pulmonary disease is a chronic progressive lung illness characterised by 
obstruction in the airway that cannot be fully reversed. In people living with COPD, their 
airways will be narrowed. The symptoms quite often include breathlessness on minimal 
exertion and an increased sputum production. The recent Global Initiative for Chronic 
Obstructive Lung Disease (often referred to by the acronym GOLD)  defines COPD as “a 
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common preventable and treatable disease, which is characterised by persistent airflow 
limitation that is usually progressive and associated with abnormal inflammation response of 
the lung to noxious particles or gas” (GOLD website, 2016). Barnes, Rennard, and Thomson 
(2009) estimated that 70-80% of the COPD cases were caused by cigarette or tobacco 
smoking. Other causes include environmental smoke inhalation (such as industrial fumes, air 
pollution, occupational exposure to dust, and indoor biomass fuel burning) and genetic 
abnormalities (such as alpha-1 antitrypsin deficiency) (Soriano & Lamprecht, 2012). There is 
a variety of common treatments for people living with COPD which include pulmonary 
rehabilitation, medications, and long-term oxygen therapy. 
It is anticipated that people living with COPD will benefit from a PR programme, the focus 
of this thesis. Pulmonary rehabilitation programmes have also been mentioned in the 
literature to be effective with other chronic respiratory conditions such as asthma, interstitial 
lung diseases, pulmonary artery hypertension, non-cystic fibrosis bronchiectasis, and non-
small cell lung cancer, by improving quality of life, exercise performance, and fatigue levels 
(Holland, Wadell, & Spruit, 2013). 
The burden of COPD  
Soriano and Lamprecht (2012) indicated that COPD has become one of the major health 
burdens in the world. In 2012, an estimated 210 million people were living with COPD and it 
caused the death of at least 2.9 million people worldwide. It was estimated that 1.1 billion 
people in the world were current smokers, the major cause of COPD. The authors also 
pointed out that COPD was the fourth leading cause of death since the year 2000 and 
conservative projections suggested that the by the year 2020, COPD would become the third 
leading cause of death worldwide (Soriano & Lamprecht, 2012; WHO COPD website, 2016).  
In 2010, it was projected that COPD had had a significant impact on the United States’ health 
system and productivity, costing as much as USD 49.9 billion a year (Mannino et al., 2015). 
The amount was broken down to USD 29.5 billion of direct medical costs, USD 8 billion on 
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indirect morbidity cost (lost productivity cost due to illness) and USD 12.4 billion on indirect 
mortality costs (loss of productivity due to premature death). The main reason for the high 
economic cost in treating people living with COPD is due to its complexity and systemic 
influences on the body (Baty et al., 2013). Baty et al. (2013) reported a cluster of 
comorbidities (other medical conditions) are commonly seen in people living with COPD: 
cardiovascular diseases (ischaemic heart disease, heart failure, etc.), respiratory tract diseases 
(obstructive sleep apnoea, pneumonia, etc.), metabolic diseases (type II diabetes, 
dyslipidaemia, etc.), haematological diseases (anaemia, pulmonary embolism, etc.), 
musculoskeletal diseases (muscle dysfunction, osteoporosis, etc.), gastro-intestinal diseases 
(reflux, liver cirrhosis, etc.), renal diseases (renal dysfunction), psychiatric diseases 
(depression, anxiety, etc.), and cancers (lung, pancreas, etc.). Mannino et al. (2015) went a 
step further by quantifying the percentages of each of the major comorbidities and they 
reported from their retrospective observational study, 34.8% of people living with COPD had 
cardiovascular disease, 22.8% had diabetes, 14.7% had asthma and 14.2% had anaemia. The 
authors also found that more than half of the COPD population studied (52.8%) had more 
than one comorbidity (Mannino et al., 2015). These comorbidities not only increased the cost 
of care for people living with COPD (Mannino et al., 2015) but also increased the annual 
hospitalisation rate, increased the length of hospital stay, and increased the in-hospital 
mortality rate (Baty et al., 2013), thus being a significant burden to the health care system and 
society. 
The 2013 National Health Committee Strategic Overview of Respiratory Disease in New 
Zealand revealed a similar pattern in New Zealand to that seen in the international data: a 
high economic cost to treat people living with COPD in New Zealand because of their higher 
hospital admission rates, longer hospital stay, and higher mortality rate (New Zealand 
Ministry of Health, 2013). The prevalence rate for New Zealand adults, 45 years of age and 
above, who were living with COPD was 6.6%. This percentage was equated to 96,100 adults 
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or 1 in 15 individuals over 45 years of age. The survey may have uncovered a small portion 
of the true COPD population mainly due to the under-diagnosing of the illness. Another New 
Zealand study by Shirtcliffe et al. (2007) found an age-adjusted prevalence rate of 14.2% for 
adults aged over 40 years of age. The underestimation was attributed to under-diagnosing of 
the COPD condition due to lack of understanding and diagnosing tools (spirometer) among 
GPs. It is also worth noting that COPD normally would present itself later in life; it is an age 
related disease. If we apply the above percentage values to the Canterbury region, in New 
Zealand, we can appreciate the significance of the issue and its burden to the healthcare 
system. According to the 2013 Census (Statistics New Zealand, 2013) there were 539,436 
people were living in the Canterbury region, 47.4% were above the age of 40 (47.5% male, 
52.5% female). These values would suggest a prevalence estimate of 16,876 to 76,600 people 
living with COPD in the Canterbury region. The 2013 National Health Committee Strategic 
Overview of Respiratory Disease in New Zealand also revealed the Māori population had 
twice the prevalence in COPD compared to people of other ethnic groups. It also reported 
women living in the more deprived regions were more likely to have COPD than their 
counterparts living in more affluent areas. Chronic obstructive pulmonary disease accounted 
for 1,523 deaths in 2006, 39% of the total respiratory deaths. 
The high cost of looking after people living with COPD is also worth noting. The 2006-2009 
ethnic-standardised hospitalisation rates indicated women and Māori had higher hospital 
admission rates. A Health Needs Assessment for the Central Region’s District Health Boards 
report (2008) cited COPD as accounting for 95% of avoidable respiratory death. From an 
OECD health report (2011), New Zealand has the second highest COPD admission rate, 
second only to Ireland. The cost of providing treatments to the COPD patients in New 
Zealand was estimated to be NZD 102 million to NZD 192 million per annum (Town, Taylor, 
Garrett & Patterson, 2003). The average cost of care per patient per year was estimated to be 
NZD 2,566 (compared to NZD 2,500 for asthma), this amount did not take into consideration 
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other financial costs from loss of income, the costs to family, or loss of quality of life. 
Chronic obstructive pulmonary disease patients had a longer hospital stay as well, with an 
average of 4.2 days (compared to 1.3 days for asthma), costing a grand total of NZD 54 
million in hospitalisation (20.3% of total respiratory hospitalisation cost). 
Pulmonary Rehabilitation 
The pulmonary rehabilitation programme is an evidence-based health intervention (Ries et 
al., 2007). It has been shown to reduce the risk of hospital admissions and mortality in people 
living with COPD (Puhan, Scharplatz, Trooters, & Steurer, 2005). The pulmonary 
rehabilitation programme has demonstrated that it can decrease the participants’ dyspnoea, 
fatigue levels, and give a sense of control over their respiratory conditions (Lacasse, Maltais, 
& Goldstein, 2004). McCarthy et al., (2015) in their Cochrane review on the effects of 
pulmonary rehabilitation on people living with COPD concluded that, due to strong evidence, 
no further RCTs are warranted to test the positive effects of pulmonary rehabilitation. In their 
review of 65 RCTs involving 3,822 participants they reported a statistically significant 
improvement for all functional and exercise capacity outcomes in the participants of 
pulmonary rehabilitation. Respiratory physicians in Canterbury have described pulmonary 
rehabilitation to be “at least as effective as inhaled medications” (Canterbury 
HealthPathways, 2016).  
The American Thoracic Society (ATS) and the European Respiratory Society (ERS) have 
jointly defined pulmonary rehabilitation, which the Canterbury Community Pulmonary 
Rehabilitation Team has accepted as: 
a comprehensive intervention based on a thorough patient assessment followed by 
patient-tailored therapies that include, but are not limited to, exercise training, 
education and behaviour change, designed to improve the physical and psychological 
condition of people with chronic respiratory disease and to promote the long-term 
adherence to health enhancing behaviours (Spruit et al., 2013). 
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Puhan et al. (2005) conducted a systematic review of RCTs on the benefits of pulmonary 
rehabilitation for COPD patients. The authors focused on finding trials relating to patients 
attending the pulmonary rehabilitation programme after an acute exacerbation episode. In the 
review, Puhan et al. (2005) identified six trials with a total of 230 patients. The authors 
reported a relative risk ratio for unplanned hospital admission of 0.26, favouring the 
pulmonary rehabilitation approach instead of the usual care approach when treating patients 
living with COPD. In other words, for every 100 COPD patients only 26 COPD patients who 
had pulmonary rehabilitation had an unplanned hospital admission. The review also reiterated 
the positive influences on quality of life that pulmonary rehabilitation is able to bring about 
for the COPD population. The majority of pulmonary rehabilitation programmes use the 
CRQ or the St George Respiratory Questionnaire (SGRQ) to measure patient self-reported 
quality of life in the fatigue, emotional function, mastery, and dyspnoea domains. This 
systematic review reported that there was a consistent effect favouring the pulmonary 
rehabilitation approach when the primary outcome measure was the quality of life of the 
COPD patients. Puhan et al. (2005) used exercise tolerance as an outcome measure and 
reported that all the reviewed journals indicated the favourable effect of pulmonary 
rehabilitation on the six-minute walking test (SMWT) in COPD participants. The reported 
mean difference outcome in the reviewed articles exceeded the minimal clinical significance 
difference value of 53 metres which was set by the authors. The minimal clinically important 
significant difference is different from the statistical significant value. A statistically 
significant change is where a p-value is used to determine the level of statistical significance. 
The minimal clinical important difference is defined as the smallest difference measurable by 
a validated assessment tool which indicates a meaningful clinical change in the condition, for 
better or worse. This perception of change can be reported by the patient, clinician or 
investigator involved (Spruit et al., 2013) and is used in clinical practice where meaningful 
clinical change is the primary outcome of interest.  
7 
 
In the Puhan et al. (2005) review, pulmonary rehabilitation was shown to improve the 
survival of people living with COPD. The relative risk ratio for mortality was 0.45 for 
pulmonary rehabilitation participants, which indicates that for every 100 COPD patients 55 
would have an improved survival rate by attending pulmonary rehabilitation. The pulmonary 
rehabilitation participants had longer survival days if they were admitted to a respiratory 
intensive care unit compared to the patients who had no exposure to the pulmonary 
rehabilitation. The authors indicated, provided the participants started their own individual 
walking training, pulmonary rehabilitation was able to improve the mortality rate. 
Pulmonary rehabilitation is not only effective but also one of the most economical ways of 
managing people living with COPD. From the literature search, I found the savings from 
pulmonary rehabilitation varied greatly. Golmohammadi, Jacobs and Sin (2004) undertook an 
economic evaluation of their community-based pulmonary rehabilitation programme in 
Canada. They reported at one year after participants attended the pulmonary rehabilitation 
programme there was an improvement in self-perceived health, associated with decreased 
health care utilisation and reduced direct health costs. There was a total saving of CAD34,367 
per 100 person-years or about CAD344 (NZD 406) per person per year. A more recent study 
by Chakravorty, Fasakin, Paine, Narasimhaiah, and Austin (2008) also looked into the direct 
cost-saving that pulmonary rehabilitation programmes can achieve in the United Kingdom. 
They concluded that the pulmonary rehabilitation programme was economical mainly due to 
its ability to reduce inpatient hospital stays for people living with COPD (2.35 days) and in 
primary health utilisation. A total of GBP1,835 (NZD 4,207) was saved from the health 
system per person in the 12 months post pulmonary rehabilitation. 
Internationally, the current pulmonary rehabilitation evidence supports that exercise training 
and facilitating behavioural changes in the self-management in people living with COPD are 
effective, however, a consensus on the ideal pulmonary rehabilitation programme structure, 
duration and staff-to-patient ratios is still to be reached (Spruit et al., 2013; Bolton et al., 
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2013; Spruit et al., 2013). In the McCarthy et al. (2015) Cochrane systematic review, the 
authors identified similar issues concluding that there was a wide range of methods and 
models used in different countries to delivering pulmonary rehabilitation. It is, therefore, 
difficult to describe the optimal pulmonary rehabilitation programme structure due to the 
heterogeneous nature of the programme delivery and outcomes (McCarthy et al., 2015; Spruit 
et al., 2013; Bolton et al., 2013). Bolton et al., (2013), when they developed the latest 
pulmonary rehabilitation guidelines for the British Thoracic Society (BTS), recommended 
that pulmonary rehabilitation programme duration should be 6-12 weeks and that it should be 
offered to people living with COPD with a view to improving exercise capacity, dyspnoea, 
health status, and psychological wellbeing by a clinically important amount. The authors’ 
recommendations were based on Grade A evidence, which was defined as having at least one 
high quality meta-analysis, systematic review, or RCT and directly applicable to the target 
population with an overall consistency in the results demonstrated (Bolton et al., 2013). 
Spruit et al. (2013), when developing the ATS/ ERS guideline on pulmonary rehabilitation, 
had identified the lack of clarity in the international literature on the best format for 
delivering pulmonary rehabilitation. However, based on the current available evidence and 
expert opinion, the guideline recommended the pulmonary rehabilitation programme should 
be at a minimum of eight-weeks long for the participants to experience some clinical 
improvement. A literature search on the optimal number of sessions per week and the staff-
to-patient ratios remains inconclusive (Spruit et al., 2013). 
Based on the current evidence, both the BTS and ATS/ERS guidelines were unable to 
establish the optimal structure and format in delivering pulmonary rehabilitation. both 
guidelines did agree on three aspects: 1) pulmonary rehabilitation is clinically effective in 
improving the symptoms and the health status of the people living with COPD, 2) exercise 
training is clinically effective in improving the prognosis and wellbeing of the people living 
with COPD, and lastly 3) behavioural change and collaborative self-management through 
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education and information sharing (a component of pulmonary rehabilitation) can reduce 
health care use. 
Research hypotheses 
1. The CRQ results will demonstrate the home-based pulmonary rehabilitation performs 
no worse (no statistically significant difference) than the traditional centre-based 
pulmonary rehabilitation in all four domains (dyspnoea, fatigue, emotional function 
and mastery) of the questionnaire.  
2. The 1MSTST, the standardised exercise capacity test in the Canterbury centre-based 
pulmonary rehabilitation, will demonstrate a significant improvement in the home-
based pulmonary rehabilitation.  
Research objectives 
There were two stated investigation objectives to this research project. First, this research 
aimed to establish the clinical effect and performance of the home-based pulmonary 
rehabilitation through the CRQ. The CRQ is a validated, respiratory, and disease-specific 
quality of life questionnaire. Second, this research would be able to demonstrate an objective 
change in the 1-minute sit-to-stand test, a quick exercise testing tool. This thesis would then 
be able to make some recommendations to the future service providers of the home-based 
pulmonary rehabilitation by exploring the above three objectives. 
In Summary 
The majority of the participants on the PR programmes are living with COPD, a progressive 
illness that causes shortness of breath on minimal exertion, an increase in sputum production 
and eventually premature ageing and death. The illness causes significant loss of productivity 
and management cost to the health system. Pulmonary rehabilitation is one form of effective 
and evidence-based treatment to people living with a chronic respiratory condition. In 
Canterbury, the programme has been described by the respiratory physicians to be at least as 
effective as the medications that are inhaled (Canterbury HealthPathways, 2016). The 
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pulmonary rehabilitation programme is known to improve the health status, prognosis, and 
wellbeing for people living with COPD through knowledge, exercising, and a reduction in 
isolation. 
There are four main foci to this thesis project. 1) To investigate an alternative way of 
delivering pulmonary rehabilitation for people like Jason. 2) To validate the effect of the 
chosen alternative pulmonary rehabilitation option and lastly, 3) to make recommendations to 





Chapter 2: Literature Review 
Introduction and guide to the reader 
As mentioned previously, internationally, the physiological mechanisms underpinning COPD 
and the effects of pulmonary rehabilitation on managing people living with COPD have been 
studied extensively and supported. In practice, however, the low uptake of pulmonary 
rehabilitation programmes continues to be a central issue, because many COPD patients who 
could benefit from participation in a pulmonary rehabilitation programme are not taking part. 
In the case scenario provided earlier, Jason was unable to attend a pulmonary rehabilitation 
programme due to his work commitments and the significant amount of travelling that would 
be involved if he were to attend a pulmonary rehabilitation programme at a city venue – a 
two-hour round trip by car. This review examines the literature, both locally and 
international, to investigate the issues and reasons for the low attendance at centre-based 
pulmonary rehabilitation programmes. The literature review also explores the evidence on 
alternative pulmonary rehabilitation delivery options, namely the home-based programme. If 
a home-based programme is found to be effective, this delivery option would offer people 
like Jason a new opportunity to learn more about, and improve, his breathing condition. The 
review also presents the evidence for the objective measures used in this research project. In 
brief, there are two main questions that frame the literature review: 
1. What are the current research findings about low attendance to the pulmonary 
rehabilitation programmes? 
2. What current evidence informs home-based pulmonary rehabilitation programmes? 
Electronic databases, Google Scholar and PubMed, were searched from the time this thesis 
project was conceptualised to April 2016. To be included, the articles needed to specify that 
participants were living with a confirmed diagnosis of a chronic respiratory condition; the 
participants must be older than 18 years of age; the articles must be written in English or have 
been translated to English and lastly, the keywords used in the search must have been 
mentioned either in the title or the abstract of the article. The articles were excluded if 
12 
 
participants had not been diagnosed with a chronic respiratory condition or if they had 
attended programmes other than the pulmonary rehabilitation. The main search keywords 
used for identifying low pulmonary rehabilitation attendance were: “COPD”, “pulmonary 
rehabilitation”, “adherence”, “compliance”, “attendance”, “attendance”, “analysis” and 
“review”. Two local and three international articles were identified as relevant from the initial 
80 search results. Key words used in the search for the evidence on the home-based 
pulmonary rehabilitation were “home-based”, “home based”, “home-based pulmonary 
rehabilitation”, “COPD”, “review” and “analysis”. A total of 12 studies were identified, from 
the initial 85 search results, and interestingly the search did not produce any local home-
based pulmonary rehabilitation studies. Lastly, evidence behind each of the routine 
pulmonary rehabilitation objective measures were explored and explained. 
 
Pulmonary Rehabilitation in Canterbury 
The first Canterbury pulmonary rehabilitation programme was run in the late 1980s as a joint 
venture between the Physiotherapy Department and Cardio-Respiratory Outreach Services, 
Christchurch Hospital. After it was established, and for the next 20 years, pulmonary 
rehabilitation programmes were run centrally at one venue, the Christchurch Horticultural 
Hall. Since the establishment of the Community Respiratory Services (CRS) the pulmonary 
rehabilitation service has continued to evolve to meet patient needs. The community 
pulmonary rehabilitation team is now supporting nine pulmonary rehabilitation programmes 
in eight different venues across Canterbury (Amberley, Rangiora, City North, City East, 
Central East, Central South, City West, and Ashburton) (HealthInfo,). The clinical reasoning 
behind the different venues was to improve patient access to this effective intervention for 
people living with chronic breathing illnesses with the intention that this would translate to 
better adherence and attendance to the pulmonary rehabilitation programme. 
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In Canterbury, the pulmonary rehabilitation programme is eight-weeks long, two sessions per 
week, and two hours per session. The two hours consist of one hour of exercise and one hour 
of education. The exercise component of the programme is delivered by setting up a gym 
circuit with some simple gym equipment, such as Thera-Bands, weights, seated bikes, steps, 
stairs, and exercises involving a chair, a wall and a table (see Figure 1). 
 
Figure 1. Exercise circuit for a pulmonary rehabilitation programme. 
 
The time spent on each exercise station starts at three minutes and gradually increases to five 
minutes per station towards the end of the programme. The gradual increase in time reflects 
the fitness improvement gained over the course of the programme. The education component 
of the pulmonary rehabilitation programme involves presentations and dynamic discussions 















Figure 2. Education sessions for a Canterbury pulmonary rehabilitation programme. 
The specialist speakers include a respiratory physician, clinical psychologist, physiotherapist, 
nurse specialist/educator, dietician, pharmacist, social worker, occupational therapist, and 
community exercise group representatives (Green Prescription, Respiratory Relief Society, 
and the like). The aim of the education sessions is to empower the pulmonary rehabilitation 
participants with more knowledge about their breathing conditions and strategies to enable 
the pulmonary rehabilitation participants to live more positively. 
In Canterbury, “Health Pathways” (Canterbury HealthPathways: 
http://www.healthpathways.org.nz/, accessed 2014) provide detailed guidelines to GPs on the 
management of people living with COPD in the community. The ideal management pathway 
for those over 40 would be to first, make a confirmed diagnosis of COPD by arranging a 
spirometry for people who are breathless, and then take a smoking history. Second, if they are 
still a smoker, those living with COPD should be advised of smoking cessation strategies, and 
referred to a pulmonary rehabilitation programme. Influenza immunisation, a COPD action 
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plan and dietary support are also important. GPs can make referrals to other allied health 
professionals, for example, to a respiratory physiotherapist, if the patient is struggling with 
clearing his/her phlegm. GPs are also advised to refer the patient to a respiratory physician 
for a consultation if the case is complex. Overall, in Canterbury, there is a comprehensive 
integrated respiratory service structure for people living with COPD, ranging from the 
community health care professionals (GP, practice nurse visits), to the integrated respiratory 
services (pulmonary rehabilitation, breathing test, and sleep study), to tertiary care services 
(specialist consult) for the more complex cases. 
Unfortunately the movement of the pulmonary rehabilitation programmes to patients’ 
neighbourhoods made limited improvement to attendance and adherence numbers. According 
to the Canterbury Clinical Network (http://ccn.health.nz/, data accessed 30th February 2016) 
in the period January 2014 to January 2015, the pulmonary rehabilitation team had received a 
total of 506 referrals from the pulmonary rehabilitation database. Despite the ability to offer 
patients the choice of attending a pulmonary rehabilitation programme close to home, on the 
first telephone contact, 299 patients (close to 60%) declined the offer to attend a programme. 
Altogether, 207 patients agreed to participate in the programme a further 62 patients (30%) 
withdrew or did not complete  the programme (i.e. attended fewer than eight out of 16 
sessions) for various reasons. In other words, from the time of receiving the appropriate 
referrals, just over 70% of the patients dropped out of the programme. These values are 
consistent with Australian counterparts. Keating and Holland (2011) found 8 to 50% of 
referred patients never made it to a pulmonary rehabilitation programme and 10 to 32% of the 
patients who started a programme did not complete it. Knowing the severity of the issue, it 
was proposed and agreed by the Pulmonary Rehabilitation Working Group in July 2014 to 
pilot an alternate form of pulmonary rehabilitation: a home-based pulmonary rehabilitation 
programme to tackle the low completion rate. This home-based pulmonary rehabilitation 
programme is the focus of this thesis. 
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Low attendance in Pulmonary Rehabilitation programmes- New Zealand literature: 
Levack, et al. (2012), is the only known academic paper on the New Zealand context that 
examined the uptake of pulmonary rehabilitation in New Zealand in 2009. The results 
showed less than 1% of the New Zealand COPD population were referred to a pulmonary 
rehabilitation programme. The authors sent out surveys by post to all identified pulmonary 
rehabilitation providers in New Zealand and requested information on the characteristics of 
the pulmonary rehabilitation programmes and the estimated numbers who had been offered 
pulmonary rehabilitation, entered and completed a pulmonary rehabilitation programme. The 
response rate to the survey was high (91%). Twenty-one out of the 23 identified pulmonary 
rehabilitation providers, 16 from the District Health Boards (DHB), five from the Primary 
Health Organisations (PHO), one from a DHB/PHO partnership and one from Non-
Government Organisation (NGO), responded. The survey results showed a total of 2,569 
people living with COPD were offered pulmonary rehabilitation; 1,786 entered a pulmonary 
rehabilitation programme and 1,378 had completed a pulmonary rehabilitation programme in 
2009. Shorncliffe et al. (2007) estimate 14.2% of adults over the age of 40 have COPD, and 
therefore it was calculated that in 2009, New Zealand was likely to have 213,400 to 329,800 
people living with COPD. The results showed a conservative estimate of only 0.9% of the 
COPD population in New Zealand had been referred to a pulmonary rehabilitation 
programme. Although the estimated value appeared discouraging, it was in line with similar 
survey findings undertaken in the United Kingdom and Canada (Brooks et al., 2007; 
Yohannes & Connolly, 2004). Levack et al. (2012) speculated that the main causes of the low 
uptake rate in New Zealand maybe due to “the lack of direction and lack of financial 
incentives offered at the public policy level”. Levack and colleagues (2012) explained further 
by stating the undeniable importance of smoking cessation as the best treatment for people 
living with COPD, but the need for pulmonary rehabilitation will continue to exist for at least 
20 to 30 years after New Zealand meets the ‘Smokefree’ status in 2025. Therefore, it is 
important for the respiratory service in the national, regional and local levels to have strong 
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leaders to continue to drive this effective intervention for people living with COPD (Levack 
et al., 2012). 
Many studies locally and internationally have investigated reasons for the low participation 
rate in this effective treatment for people living with COPD (Ramage et al., 2016; Keating, 
Lee & Holland, 2011; Harris, Hayter & Allender, 2008; Fischer et al., 2009). Ramage et al. 
(2016) explored the factors associated with non-attendance to the community pulmonary 
rehabilitation in the Canterbury region. The project was a mixed method cohort study of 
patients referred to the Canterbury community pulmonary rehabilitation. A series of 
standardised quantitative and qualitative interview questions were developed using the HADS 
and some adaptations from the Subjective Health Complaints (SHC) inventory. There were a 
total of 154 eligible participants, 75 participants completed the interview (48.7%), 70 could 
not be contacted, and 9 did not wish to participate in the study. The mean age for the 
completed group was 68.5 years and 64.2 years for the could-not-be-contacted group. The 
gender and ethnicity distributions were similar in both groups. Inductive thematic analysis 
was carried out to investigate trends and themes in the interview transcripts. The analysis 
identified five main themes for not attending a pulmonary rehabilitation: conflict with 
everyday life, travel, fears and anxiety, belief and understanding about pulmonary 
rehabilitation, and a lack of perceived pulmonary rehabilitation benefits. Based on these 
qualitative and quantitative findings Ramage et al. (2016) made some recommendations to 
the pulmonary rehabilitation services on ways to tackle the low pulmonary rehabilitation 
attendance. The authors recommended that information sharing with the referring clinicians 
and the patients should be reviewed and made easier for people who access it. The 
information sharing pathways such as the Canterbury HealthPathways (as mentioned 
previously a GP tool), pulmonary rehabilitation referral form and pulmonary rehabilitation 
information pamphlet should be updated with relevant and user friendly information. Other 
recommendations from the report included rebranding of pulmonary rehabilitation to a more 
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meaningful name to the users and establishing an alternative method of delivering pulmonary 
rehabilitation to capture the younger working users who missed out on the current pulmonary 
rehabilitation services, such as online delivery, evening after-work programme, and a home 
programme. 
Low attendance in Pulmonary Rehabilitation programmes- International Literature 
Overseas, the study by Keating, Lee, and Holland (2011) identified a few stand-out factors 
for the low attendance to the pulmonary rehabilitation programmes in their systematic review 
of the literature. A total of 796 articles were identified in the initial database search. After 
removing duplicates and filtering of the inclusion and exclusion criteria, 11 articles remained. 
To be included in the review, the subjects needed to have a confirmed diagnosis of COPD, 
have participants 18 years or over, be written in English, and have factors associated with 
non-attendance or non-completion of PR as part of the discussion. The exclusion criteria for 
the articles were if the subjects were not diagnosed with COPD and were attending a 
programme other than a pulmonary rehabilitation one. In the eleven articles selected, the 
demographic characteristics of the participants showed a wide spectrum range. The disease 
severity ranged from mild to very severe COPD. The mean age of the population ranged from 
61 to 75 years of age and the majority of the studies had more men than woman as the listed 
participants. From the qualitative studies, the authors found a lack of perceived health benefit 
from attending pulmonary rehabilitation, patient’s perception of using exercise as a treatment 
to their breathing condition, difficulty accessing a pulmonary rehabilitation programme either 
due to poor personal mobility, lack of transport or cost of transport, and being unwell either 
due to the direct impact of COPD or other comorbidities during the course. Other minor 
factors included the time commitment to the programme, older age, fatigue, and lack of social 
or family support. The authors concluded that more effort was required in disseminating the 
proven benefits of pulmonary rehabilitation to the eligible patients and, at the same time, 
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more effort should be made to explore the different models of delivery to meet the needs of 
the patients. (Keating et al., 2011). 
Another qualitative study, by Harris, Hayter, and Allender (2008), echoed the findings of 
Keating et al. (2011); however, Harris et al. (2008) looked at the non-attendance reasons from 
the perspective of the fear of the patients in attending a pulmonary rehabilitation programme. 
The authors contacted 110 patients from a suburban general practice in north-east Derbyshire, 
United Kingdom, from which 16 patients with confirmed COPD diagnosis agreed to 
participate in the interview. The 16 participants consisted of males (12 out of 16), ex-smokers 
(14 out of 16) and had an average age of 66.8 years. Nine participants had mild COPD, five 
had moderate, and two had severe COPD. The interviewer asked six standardised topic 
questions which were themed around the participant’s experience of living with COPD and 
the participant’s perception of pulmonary rehabilitation. The responses were analysed using 
open inductive coding through line-by-line reading of the interview transcript using the 
principles of grounded theory. The results revealed patients’ fear of exercise and being 
breathless as the key themes related to pulmonary rehabilitation perception. The patients also 
mentioned the fear of pulmonary rehabilitation having a non-favourable effects on their other 
coexisting medical conditions. The authors explored other possible solutions to the fear of 
participating in a pulmonary rehabilitation programme through the structured interview 
session. They identified some motivators that may help to reduce the fear factor. Motivators 
such as pulmonary rehabilitation has the potential to reduce the sensation of breathlessness, 
regaining control over life, and regaining ability to do things the patient enjoys. Harris, 
Hayter and Allender (2008), in their conclusion, suggested the importance of acknowledging 
the patient’s fear and the need to create a positive attitude to facilitate the participant in 
understanding the potential health benefits pulmonary rehabilitation programme can deliver. 
Lastly, Fischer et al. (2009), in their qualitative semi-structured interview study, looked at the 
participation and drop-outs of pulmonary rehabilitation programmes from another interesting 
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angle. Four women and eight men living with COPD from two rehabilitation centres in the 
Netherlands were recruited to this study. The average age for the study population was 61 
years of age. Of the 12 participants, two were still actively working, six had to stop working 
due to their illness and four had retired. The authors found that there is a “continuous trade-
off between the subjective need for improvement (the anticipated attainable benefits) on the 
one hand and concerns and barriers to attending pulmonary rehabilitation classes on the 
other” (Fischer et al., 2009). The study reported from an interpretative phenomenological 
analysis, the COPD patients’ perception or beliefs about their medical condition and also 
about the management of their illness through PR, and the way that it appeared to play a 
critical role in determining the uptake or drop-out from pulmonary rehabilitation 
programmes. The patients also reported on the intensity of the pulmonary rehabilitation, lack 
of visible improvement or not achieving the anticipated improvement prior to attending the 
pulmonary rehabilitation, and other social problems could push the participants towards 
dropping-out from the pulmonary rehabilitation programme.  
Home-based pulmonary rehabilitation 
Home-based pulmonary rehabilitation had been speculated as an appropriate alternative to the 
standard centre-based pulmonary rehabilitation for all COPD patients of differing severities 
(Fernández et al., 2009; Boxall et al., 2005; McFarland et al., 2012; Strijbos et al., 1996). In 
recent years, more studies have looked into the effects of the self-monitored home-based 
pulmonary rehabilitation (Maltais et al., 2008; de Oliveira et al., 2010; Jolly et al., 2007; 
Ghanem et al., 2010; Hernadez et al., 2000; Khoshkesht et al., 2015; Burkow et al., 2015; 
Majewski et al., 2015). 
Majewski et al. (2015) demonstrated the effects of a home-based pulmonary rehabilitation 
programme for older females living with bronchial asthma. The clinical trial involved 10 
participants who had completed the programme, with a mean age of 70.8 years and body 
mass index of 24.6. The participants were students at the University of the Third Age in 
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Wroclae, Poland, and all of them were living with diagnosed mild to moderate bronchial 
asthma. The authors used the SGRQ to evaluate the health-related quality of life of the 
participants. The Fullerton Functional Fitness test and the six-minute walking test were the 
main exercise capacity objective measures. Other objective tests used were the modified Borg 
scale, the Medical Research Council scale for breathlessness level, spirometric values, and 
the HADS for mental status. The programme ran for eight weeks with two home exercise 
sessions and one supervised exercise session per week. On completion of the eight-week 
programme, the authors found significant improvement to the participants’ breathing muscles 
and spirometric readings. Their results also suggested significant improvement in the exercise 
capacity of the participants, with a statistically significant improvement in the lower body 
flexibility trial and six-minute walking test distance (mean change of 36 metres, p< 0.05). 
Maltais et al. (2008) conducted a multicentre, randomised and non-inferiority trial to examine 
the effects of the home-based pulmonary rehabilitation in patients with COPD. Two hundred 
and fifty-two patients participated in this study across 10 different academic and community 
medical centres in Canada. All the participants were invited to attend standardised education 
and self-management sessions over a four-week period. The patients were then randomly 
assigned to either a home-based programme or to an outpatient hospital-based rehabilitation 
programme for 8 weeks. Once the participants completed the 12-week programme they were 
followed up for 40 weeks to map out their one year trend. Their primary outcome measure 
was the CRQ. The results at the one year mark showed a similar improvement between the 
home-based and the centre-based programmes and the difference between the two 
intervention groups was “small and clinically unimportant” (Maltais et al., 2008). The authors 
concluded that the home-based pulmonary rehabilitation was no worse than, if not equal to, 
the effects of a hospital centre-based pulmonary rehabilitation in the COPD population. 
In Brazil, de Oliveira et al. (2010) did a randomised controlled prospective study with 117 
COPD patients, comparing the effects of an outpatient-based pulmonary rehabilitation and a 
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home-based pulmonary rehabilitation. The patients were recruited from a private 
pulmonology clinic and randomly allocated to one of three different groups: home-based 
pulmonary rehabilitation, outpatient pulmonary rehabilitation and a control group. The home-
based pulmonary rehabilitation group patients were informed to perform all pulmonary 
rehabilitation activities unsupervised at home. The outpatient pulmonary rehabilitation group 
participants performed all the pulmonary rehabilitation activities in a clinical setting, 
supervised by a physiotherapist. The control group participants did not perform any 
pulmonary rehabilitation activities. The patients consisted mainly men in all three groups 
with a mean age of 66.4 years for the home-based, 71.3 years for the outpatient group and 
70.8 years for the control group. All patients received a one-off education session on the 
initial evaluation day. The education session covered the topics regarding the development 
and progression of COPD, all available treatments for COPD, oxygen therapy, and the 
importance of an exercised-based rehabilitation. The programme ran for 12 weeks. The 
primary outcome measures for this study were six-minute walk distance and Body-mas index, 
Obstruction, Dyspnoea, and Exercise index (BODE), which is a multidimensional scoring 
system in predicting the survival rate of a COPD patient. The results of the trial showed that 
both home-based and hospital-based programmes produced statistically significant 
improvements to the patients’ six-minute walking distances and also the BODE index scores. 
The authors of this study also suggested that the home-based self-monitored pulmonary 
rehabilitation is an effective alternative to the standard centred-based pulmonary 
rehabilitation.   
Ghanem et al. (2010) undertook a randomised clinical trial in Egypt where they recruited a 
total of 39 participants living with COPD after they were discharged from an acute admission 
to the local hospital. The participants were randomly allocated to two different groups: the 
home-based pulmonary rehabilitation group (25) and the control group (14). The home-based 
group participants were assessed and educated prior to their discharge from the hospital and 
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the control group participants did not receive any pulmonary rehabilitation education and 
were cared for according to the local usual medical care for people living with COPD. Those 
in the home-based programme were monitored and reviewed after two months. The main 
outcome measures used in this clinical trial were the six-minute walking distance, CRQ, and 
quality of life scale Short Form (SF-36). The mean ages for the two groups were 56.96 years 
for the home-based group and 56.43 years for the control group. The article did not specify 
the gender distribution. Most of the participants had moderately severe COPD. At the final 
end-of-programme assessment, the home-based pulmonary rehabilitation showed a 
statistically significant improvement in the six-minute walking distance and in both quality of 
life questionnaires when compared to the control group. The authors found at the two-month 
period, that the home-based pulmonary rehabilitation was an effective way of managing 
people living with COPD after an acute hospital admission, 
Burkow et al. (2015) conducted a mixed-pilot study on ten people mostly living with severe 
to very severe COPD, from the county of Troms, northern Norway. This nine-week long 
home-based online programme was based on the outpatient pulmonary rehabilitation model 
run at the University of North Norway, where the participant would receive once a week 
online education session and two online exercise sessions per week. The main objective 
measure used was the SGRQ. There were five males and five females in the group with a 
mean age of 61.7 years (range 46-72 years). On completion of this small sample-sized study, 
the authors found a probable clinically significant improvement in the SGRQ total score 
(mean change 6.53, p< 0.05). Burkow et al. (2015) reported the participants found the online 
interface easy to use and that it was able to improve participants’ social interaction through 
the online media platform provided. This was especially important because three of the 
participants in the group lived 180-220 km away from the main outpatient clinic. The authors 
felt that despite the small sample size, the home-based online pulmonary rehabilitation was a 
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feasible option for people living with COPD and the technological involvement appeared to 
be well accepted by the study participants. 
Based on the decision of the pulmonary rehabilitation working group and also the literature 
review findings, a pilot study for a home-based pulmonary rehabilitation programme in 
Canterbury was commissioned to meet the needs for people like Jason, would benefit from 
pulmonary rehabilitation but unable to attend. There are two main objectives to this pilot 
study.  
1 Could the alternative Home-based Pulmonary Rehabilitation Programme perform 
comparably to the standard Centre-based Pulmonary Rehabilitation Programme in the quality 
of life measure, using the Chronic Respiratory Questionnaire?  
2. Could the participants in the Home-based Pulmonary Rehabilitation Programme 
perform at the same level as the Centre-based Pulmonary Rehabilitation Programme 




Chapter 3: Methods 
The study population 
The study population was recruited from people living with COPD in the community, 
referred by health professionals, but mainly by GPs and respiratory physicians, to the 
Canterbury community pulmonary rehabilitation programme (four locations: North City, East 
City, West City and Central City) between the years 2010 to 2014.  The study population was 
the non-attenders and non-completers (completed less than half of the programme sessions) 
referred to the pulmonary rehabilitation programmes over this five-year period. As mentioned 
previously, prior to this project, there were no community rehabilitation services available to 
look after people living with chronic respiratory conditions. The Community Respiratory 
Services Team has been storing these referred but unable-to-attend people in their database 
and this was accessed for the purposes of this study.  
Setting 
The study took place in Canterbury, New Zealand. The population in Canterbury, at the 2013 
Census, was close to 540,000 people. The main primary health organisation (PHO) servicing 
the mid and upper Canterbury area is Pegasus Health (Charitable) Limited. The Pegasus 
Health (Charitable) Limited PHO was established in 1992 “when a group of Christchurch 
general practitioners met to see how they could use the ‘health reforms’ of the time to get a 
better deal for the local community” (Pegasus Health website, 2016). The early Pegasus 
Health pioneers attracted a majority of the Christchurch based GPs and formed an 
Independent Practitioner Association (IPA) with a strong focus on the clinical education and 
reducing health funding wastage (Pegasus Health website, 2016). Currently, Pegasus Health 
PHO provides its services to about 80% of the general medical centres in the region with a 
combined doctor and nurse membership of about 300 members. Pegasus Health is also 
closely associated with pharmacy services in the region, providing clinical guidance and 
professional education opportunities. In the mid-Canterbury region (Ashburton to Kaikoura) 
there is a single-point of entry for referrals to the community pulmonary rehabilitation 
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service. General practice doctors play an essential role in the management of community 
dwelling respiratory patients, because they are the gatekeepers to the health and wellbeing of 
people living with chronic illness. People just like Jason, mentioned in the first chapter, a 
semi-retired farmer living with COPD, and would present themselves to their general 
practices with breathlessness issues. Once the doctor established that the breathlessness was 
due to a chronic respiratory condition through a series of spirometry results, and diagnose 
COPD, the doctor would explain all the available treatment options, including the pulmonary 
rehabilitation programme. Once the patient felt they were informed enough and agreed to a 
pulmonary rehabilitation referral, the doctor sends a referral by fax or through the electronic 
referral management system (ERMS) to the administrator of the Community Respiratory 
Services Team (CRST). The CRST is a team of 11 (an operations manager, two part-time 
respiratory physicians, two administrators, five respiratory nurses and a respiratory 
physiotherapist) who are tasked with encouraging and facilitating the integration of 
respiratory services in the Canterbury region, with a vision of creating a balanced and 
sustainable respiratory service to look after the wellbeing of all respiratory patients 
(http://www.ccnweb.org.nz/Activities/LongTermConditions/IntegratedRespiratoryService.as
px, accessed in April 2016.  
All information and communication activities are stored electronically in the CRST MEDtech 
32 patient management system, which is a communication and patient management system 
used by the majority of the GPs in the Canterbury region. On the basis of Jason’s preference 
or home location, he is then allocated to the most convenient community pulmonary 
rehabilitation programme. 
The community pulmonary rehabilitation locations are well distributed across the mid-
Canterbury region. The boundaries of the community pulmonary rehabilitation coverage are: 
Amberley to the north, Templeton to the west, New Brighton to the east and Ashburton to the 
south (Figure 3). The venue options available from north to south are Amberley, Rangiora, 
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Christchurch North, Christchurch East, Central East, Central South, Christchurch West and 
Ashburton. From 2010 to 2014 the CRST delivered on average nine community pulmonary 
rehabilitation programmes per year, with a strong focus on the eastern suburbs of 
Christchurch because it was, and still is, deemed a high need area for community respiratory 
support due to its predominantly lower socioeconomic based community background. 
 
Figure 3.The yellow spots indicate the boundary of the Canterbury community pulmonary 
rehabilitation programmes. 
 
As discussed in the literature review, the uptake of community pulmonary rehabilitation is an 
ongoing challenge to the service. On average, half of the referred patients decline the 
community pulmonary rehabilitation services on first contact. Of the remaining half of the 
referred patients, who agreed to participate in the community pulmonary rehabilitation 
service on first contact 30 to 50% of them will drop out from the course. In the calendar year 
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January 2014 to December 2014 there was a total of 506 referrals, 206 (40% of the total 
referrals) patients attended one or more sessions. In other words, 60% of the people referred 
to the community pulmonary rehabilitation programme did not want to attend or were unable-
to-attend a community pulmonary rehabilitation programme. Overall, 145 (70% of all 
attendance) completed more than half of the total 16 sessions (Report from CRST pulmonary 
rehabilitation data from Medtech, 2014). The Canterbury Pulmonary Rehabilitation Working 
Group (CPRWG) was keen to trial different formats and models of delivering the community 
pulmonary rehabilitation to improve attendance and completion rates. The home-based 
community pulmonary rehabilitation was proposed as an alternate format of service delivery 
in the August 2013 CPRWG meeting. A literature review I conducted on the effects of the 
home-based community pulmonary rehabilitation and presented to a subsequent CPRWG 
meeting. The CPRWG was keen to pilot a study on the home-based community pulmonary 
rehabilitation in Canterbury but the finer details took a few more months to develop. It was 
eventually finalised in the September 2014 CPRWG meeting and given clinical approval to 
proceed. This thesis investigates this new approach to providing pulmonary rehabilitation. 
Ethics committee approval 
An application to undertake the proposed intervention with the study group was submitted to 
and approved by the University of Canterbury Human Ethics Committee, ref: HEC 2014/69 
as a Master’s thesis research project (See Appendix B). 
After the initial submission of the human ethics application, the committee raised a few 
questions in regard to this research project. The questions could be summarised in two main 
categories: confidentiality and safety. 
Confidentiality is paramount in any clinical practice. The HEC rightfully raised questions in 
regards to how I would manage and store the patient data collected. The data collected in this 
research project was securely stored in the Canterbury Clinical Network MEDtech 32 
database. This database could only be accessed by the members of the CRST, which 
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consisted of the manager, two administrators and eight respiratory clinicians. In my role as 
the Respiratory Physiotherapist I already had role-based access to this data for the purposes 
of my work, so this would be an additional role-based access for the purposes of research 
reported in this thesis. This communication and data storage software records patients’ 
outcome measures and clinically significant conversations between the patients and 
clinicians. All data are stored for 15 years after completion of the programme for audit 
purposes.  
The HEC also raised questions about how patient and visiting clinician’s safety would be 
ensured. In this research, the recruitment, pre-programme assessment, education, intervention 
and post-programme assessment stages strictly followed the ATS and ERS Pulmonary 
Rehabilitation Guidelines (Rochester et al., 2015; Nici et al., 2006) and participants are 
remotely monitored by experienced community pulmonary rehabilitation clinicians regularly. 
The research intervention would mimic the current community pulmonary rehabilitation 
approach. The main difference would be that in this research the interventions would be 
carried out at patient’s home or the community pulmonary rehabilitation the interventions 
would be delivered in a community facility in a group setting. The visiting clinician always 
carries a mobile phone when in a patient’s home and is competent in first aid in cases of any 
medical emergency. The visiting clinician clearly documents the time of visit and where 
about they would be on their electronic diary, which other team members can access readily. 
On 30th July 2014, reference: HEC 2014/69 I had satisfied the HEC and granted approval. A 
copy of the HEC approval letter is presented in Appendix A. 
Study Design:  
This thesis study is a ten-week prospective interventional cohort study. 
Recruitment 
All the community pulmonary rehabilitation-referred patients who had been identified as 
suitable candidates were put through a query build on the MEDtech 32 database. The query 
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build is a unique filtering function in the MEDtech 32 software, which allows the user to 
screen and categorise the patients for analysis and report generating purposes. The eligible 
patients included those who, for a variety of reasons, were either unable to attend or who 
attended less than eight sessions of the full programme.  
Sample size 
A biostatistician from the University of Canterbury was approached to carry out the power 
analysis to determine the minimum sample size required for this research. The main objective 
measure for this research is the Chronic Respiratory Questionnaire (CRQ). The CRQ is an 
internationally validated assessment tool and frequently used for studies on people living with 
respiratory illnesses (Guyatt et al., 1987; Wijkstra et al., 1994; and Puhan et al., 2004). 
The power calculators used were G*Power (Faul et al., 2007, 2009), developed by the 
University of Düsseldorf and PS power and sample size calculator (Dupont and Plummer, 
1998) developed by Vanderbilt University. 
The power calculator compared the difference between two independent means for the two 
different interventions. It was assumed the CRQ results were normally distributed. The effect 
size is the minimal clinical important change value for CRQ, as suggested by Redelmeier et al 
(1996) a minimum change of 0.5 is considered a small difference in symptom, 1.0 for a 
moderate difference and 1.5 for a large difference. Historically, the Canterbury pulmonary 
rehabilitation team has been stating in their communication letters to patients that a change of 
2 is considered to be clinically significant. So in this case we selected 2 as the effect size, 
which is at the higher end of the measure used internationally. The standard deviation was 
calculated based on the research values suggested by the literature on CRQ-SR (Chronic 
Respiratory Questionnaire – Self-Reported) and they ranged from 0.7- 1.35. For the purpose 
of the power level calculation we have taken the median, 1. The alpha error probability was 
set at 0.05 as per standard practice. The power level of 0.8 was selected. The minimum 
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sample size the calculator gave was six, with a power level of 0.88. We increased the power 
level to 0.9 and the suggested sample size increased to seven.  
The biostatistician explained she would never recommend any research to be done only with 
a sample size of seven in each group. However, in this case, because the effect size is huge 
(2) the sample size needed to pick up such a big change would be small. If the effect size 
were 0.1 then to pick up such a small change a large sample size of over 1,000 participants 
would have been required.  
The Study Inclusion and Exclusion Criteria 
In this study we delivered the home-based pulmonary rehabilitation programme to the 
eligible candidates. This programme followed the clinical community pulmonary 
rehabilitation inclusion and exclusion criteria. The study then recruited patients who did not 
complete a community pulmonary rehabilitation or did not appear at any sessions as study 
candidates. The community pulmonary rehabilitation team had defined completion as 
attendance at pre-assessment and post-assessment sessions plus eight or more programme 
sessions (out of 16). The did not appear group referred to patients who the service was 
unable to establish contact with or who were given an appointment but the patient did not 
show up. 
In Canterbury, the inclusion and exclusion criteria for community pulmonary rehabilitation 
are in accordance with the American Thoracic Society and European Respiratory Society 
guidelines for Pulmonary Rehabilitation (2013) and British Thoracic Society guidelines for 
Pulmonary Rehabilitation (2013). 
Inclusion criteria: 
1. Diagnosed respiratory condition confirmed with spirometry, plus ongoing symptoms 
2. Experiencing breathlessness in their day-to-day life 
3. No cardiac event in past eight weeks 
4. Any known cardiac condition (e.g. angina) must be well controlled and stable 
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5. On optimal respiratory medication as per Canterbury COPD Pathway 
(www.healthpathways.org.nz). 
6. Motivated to attend. Discuss the programme with patient and confirm motivation on 
the referral form 
Exclusion criteria: 
1. Unstable angina 
2. Decompensated heart failure 
3. Severe hypertension (systolic > 200 and/or diastolic > 120 mmHg) 
4. Uncontrolled cardiac arrhythmias 
5. Severe aortic valve stenosis 
6. Severe arthritis 
7. Any medical problems which severely restrict exercise or compliance with the 
programme e.g., dementia, arthritis, wheelchair bound. 
Prior to the starting of the programme, the respiratory physicians, respiratory nurses, and 
respiratory physiotherapists conducted a triage session to test the suitability of the referrals 
based on the above inclusion and exclusion criteria.  
The method component of the thesis is described in the consort flowchart Figure 4 below 
bracketed in red. The flowchart described the normal pulmonary rehabilitation pathway after 
a referral was received on the left hand side of Figure 4. The flowchart also describes the two 
main sources of the home-based pulmonary rehabilitation programme referrals: the declines 
and withdraws. The declines were people who were referred and were accepted into the 
centre-based pulmonary rehabilitation programme but did-not-attend (declined) on the first 
telephone contact. The withdraws were people who were referred, accepted, and attended 
some parts but were unable to complete a centre-based programme. Participants from the two 
groups were listed as the potential home-based pulmonary rehabilitation programme 
participants. Because these potential home-based pulmonary rehabilitation participants may 
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have sat in the system for quite some time (years in some instances), for safety reasons they 




2014/15 Canterbury Home-based Pulmonary Rehabilitation Consort Flowchart with 




Assessed for eligibility (n=506) 
Declined (n= 299) 
8-week Centre-based 
Pulmonary Rehabilitation 
programme begins (n=207) 
Withdrew (n=62) 





Assessed for eligibility (n=75) 
*assessed by physician, limited by time 
Figure 4. HBPR consort flowchart with the method component in the red bracket. 
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Content of intervention 
The home-based community pulmonary rehabilitation patients were assessed by a respiratory 
physiotherapist before starting the programme. All patients were shown the education 
components of the “Move on up” DVD, which discusses the topics of importance, such as 
exercise for people living with COPD, breathing retraining, and personal stories from people 
living with COPD. 
The home-based community pulmonary rehabilitation team delivered the education and 
exercise components of the programme similar to that of a gold standard Centre-based 
Pulmonary Rehabilitation Programme. The topics that were covered include anatomy of the 
lungs, breathing techniques, respiratory diseases, chest clearance, the importance of exercise 
and stretching, goal setting, eating well, smoking cessation, medication management, 
inhalation devices and techniques, osteoporosis, stress and relaxation, energy conservation, 
sleep hygiene, a COPD self-management plan, and maintaining focus and sustaining gains. 
However, unlike the centre-based community pulmonary rehabilitation programme where 
each topic is covered by an expert speaker; the home-based community pulmonary 
rehabilitation team would identify patient’s topics of special interest during the pre-
programme assessment and offer individualised advice and direction. Patients would be 
referred to other clinical specialist/ expert intervention if deemed high risk in any categories 
of the patient’s wellbeing. All of the patients involved in the programme were given an 
information pack. The information pack included the “Move on up” exercise DVD, a ten-
week walking diary (eight weeks to complete during the programme and two extra weeks for 
after the programme had been completed), “A guide to living positively with chronic 
obstructive pulmonary disease” (3rd edition revised), a COPD Blue Card (a self-management 
guide), healthinfo keyword search card (http://www.healthinfo.org.nz/), and my 
(researcher’s) contact details. 
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The patients were instructed to do the exercises according to the “Move on up” DVD 
(Figures 5 and 6). Patients were asked to complete a walking diary, ideally on a daily basis 
over the eight weeks’ duration of the programme. The patients were informed that there 
would be a weekly telephone call or text message to maintain their interest in the programme 
and answer any questions they came up during the programme. 
The “Move on up” DVD exercises included three components: warm up, work out, and cool 
down sessions. In the warm up session the DVD took the participants through some seated 
stretches to the neck, shoulder, and back. The work out session included low-medium impact 
exercises to the lower and upper limbs aiming to improve participant’s strength and 
endurance. The cool down session included back and lower limb stretches in a standing 
position, with support as required. The DVD package also included an exercise book where 
each of the exercises was printed out in photographs with instructions for participant’s quick 
reference.  
  





Figure 6. Inside of the “Move on up” DVD with the exercises printed out in a booklet 
 
The participants were given a ten-week walking diary to help them establish their daily 
exercise routine (Figure 7). A ten-week walking diary was provided instead of an eight-week 
diary and this was to encourage the participant to keep on going upon completion of the 
programme and to consolidate the exercise component into the participant’s daily living 
routine. The diary included fields to record the day of the week on which the exercise was 
taken, minutes walked, a Borg score, and any other comments at the end of the exercise 
session. The Borg scale measures how hard one sees himself/herself exerting or working 
(Borg, 1982). The scale ranges from zero to ten, zero being not feeling the work out at all and 
ten being the maximum. By using the walking diary it is hoped that participants are 







Figure 7. All participants were given a walking diary. 
 
All participants were also given the “A guide to living positively with chronic obstructive 
pulmonary disease” booklet (Figure 8). This booklet was produced by the Cardiorespiratory 
Integrated Support Services (the Canterbury District Health Board) with the support of 
Boehringer Ingelheim, the pharmaceutical company. The booklet contained useful 
information on the management of COPD in an easy-to-understand manner. It covered 
numerous valuable topics such as medication use, pulmonary rehabilitation, clearing phlegm 
from the lungs, controlling breathlessness, nutrition facts for people living with COPD, 
anxiety and depression management. The booklet was a useful tool for the participants to 






Figure 8. “A guide to living positively with chronic obstructive pulmonary disease” booklet. 
 
The COPD Blue Card (a self-management guide) in the information pack is used widely in 
the Canterbury region. It was produced by the Integrated Respiratory Services, Canterbury 
Clinical Network (see Figures 9). The purpose of the card is to assist people living with 
COPD to determine what is normal or abnormal for them and when they should seek health 
intervention. The Blue Card included information on identifying what are the normal baseline 
values and symptoms and with advice on what to do if there were any deviations from the 





      
Figure 9. The front and back of the Canterbury Blue Card- A self-management plan for people 
living with COPD. 
 
The CDHB produced the business-card-sized Healthinfo keyword search card to assist the 
more technological savvy and Internet capable participants to access the relevant medical 
information on topics relating to COPD (see Figure 10). The Healthinfo webpage 
(www.healthinfo.org.nz) was funded by the CDHB and all the information listed on the 
webpage was approved and supported by the local health professionals. One of the intentions 
of the webpage was to avoid unnecessary confusion the patients may experience if a search 





Figure 10. A Healthinfo keyword search card. 
I also included my business card so the participants would have my contact details, both 
direct dial number and mobile phone number in case the participants wanted to communicate 
with me by text messaging. 
The aim of the package was to support the participants to learn more about their breathing 
condition and how to manage it. The walking diary and the exercise DVD would encourage 
the participant to breathe better through exercising. The information booklet, the Blue Card, 
and the healthinfo card would encourage the participant to gain more knowledge and start to 
feel more comfortable about managing the breathing condition they are living with. Figure 11 
shows the overall home-based pulmonary rehabilitation journey for the participants in this 
thesis project and the components involved in the process.  
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Initial Contact via phone call to identify 
interest and make the first appointment. 
Pre Assessment Interview; Sit-to Stand test; 




“Move on up” DVD*; 
What is COPD?; Other 
topics as identified in 
the subjective 
Assessment 
From MedTech database Search 
for patients who: 
 Came to assessment but did 
not complete 
 Attended an assessment but 
did not attend 
 Referred but did not attend 
 
 8-week  
 DVD exercise programme 
 Walking Diary 
 Weekly phone call 
 “Living positively with COPD”* 
 Continue to support and educate 
 
Post Assessment 
Interview; Sit-to Stand test; 
CAT; CRQ; HADS; MRC; Review 
goals; Community links 
 





The CRST provided the clinical staff (physiotherapist or nurses) required for the Home-based 
Pulmonary Rehabilitation Programme. The team of clinical staff all had more than 10 years 
of clinical experience and were considered to be experts in the community pulmonary 
rehabilitation area.  
Outcome measures 
Primary outcome measure 
Evidence on the selected objective COPD measures in this study  
The objective measures used in this study were the current (2016) objective assessment 
measures used in the local centre-based pulmonary rehabilitation programmes. Below is a 
brief summary and the evidence for the use of the objective measures. 
Chronic Respiratory Questionnaire (CRQ) 
This well validated questionnaire was developed by Guyatt et al. (1987), where they 
interviewed 100 patients living with chronic airflow limitation. The research team then 
identified 123 items that were problematic for these patients in their daily activities. The 
patients rated the 123 items according to their importance and occurrence. The most 
important and frequent items were classified into four main themes or dimensions: dyspnoea, 
emotion, mastery, and fatigue. These four themes formed the backbone of the CRQ. The 
dyspnoea dimension described how the patient was affected by breathlessness because of 
their chronic lung condition. The emotion dimension depicted the emotional function, 
anxiety, and depression included, of a patient living with breathing conditions. The mastery 
dimension described the feeling of control the patient had over the disease. Lastly, the fatigue 
dimension depicted the amount of tiredness the respiratory diseases patients had in their 
activities of daily living. Guyatt et al. (1987) then tested the responsiveness of the CRQ on 
patients by using the questionnaire before and after optimisation of the drug therapy and also 
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before and after the patient had attended a respiratory rehabilitation programme. The results 
from the two groups suggested the CRQ was a precise, valid, and responsive disease-specific 
tool in measuring a patient’s quality of life. In 1994, Wijkstra et al. examined the reliability 
and validity of the CRQ. Wijkstra and team found that in their 40 patients, the CRQ was a 
highly reliable and valid measure for the fatigue, emotional function, and mastery dimensions 
but less so in the dyspnoea component (Wijkstra et al (1994). To date the CRQ has translated 
into a number of languages and used in many countries around the world. The CRQ was 
translated and reviewed in the German (Puhan et al., 2004), Taiwanese (Meng et al., 2011) 
and Colombian (Álvarez et al., 2015) populations and in each instance the questionnaire was 
shown to be a valid and reliable quality of life measurement for people living with chronic 
respiratory illnesses. 
Answers to the questionnaire are converted to numerical values. A mean value change of 0.5 
per dimension, and an overall improvement of two is considered to be clinically significant 
(De Torres et al., 2002; Jaeschke et al., 1989). A copy of the questionnaire can be found in 
Appendix B.  
 
Secondary outcome measures 
One-minute sit-to-stand test (1MSTST)  
The 1-minute sit-to-stand test (1MSTST) is an assessment tool to assess the functional status 
of the patients (Ozalevli et al, 2007). The 1MSTST was performed using standardised 
instructions at the pre-programme assessment session and the test was repeated at the post-
assessment session. The number of repetitions of sit-to-stand were recorded and compared 
before and after the intervention The evidence supporting the use of 1MSTST as a simple and 
practical objective measure for exercise capacity is on the rise, despite this, most literature 
examined the exercise capacity of COPD patients using the more well-known 6-minute 
walking test (6MWT). Ozalevli and colleagues (2007) analysed the correlation between the 
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1MSTST and the 6-minute walking test and found there was a close association between the 
tests. Ozalevli and colleagues reported strong correlation was found between the 1MSTST 
and 6MWT in the COPD population with r= 0.75 (p<0.001) and a less strong correlation of 
r= 0.54 (p= 0.04) in the healthy population. The authors, therefore, suggested the 1MSTST 
produced similar assessment to the functional status of a person living with COPD; however, 
the 1MSTST was less stressful for the patients to perform. More recently, the 1MSTST was 
also tested in the cystic fibrosis, haemodialysis and pain management programme patient 
populations. Radtke et al. (2016) tested the 1MSTST on people living with cystic fibrosis and 
found the 1MSTST to be reliable, valid, and feasible when used to measure the physical 
function. The authors also suggested a minimal clinical important difference to be five 
repetitions. A minimal clinical important difference is a measure which determines when a 
change is clinically relevant. Its official definition is “the smallest difference in score, which 
patients perceive as beneficial and which would mandate a change in the patient’s 
management” (Jaeschke et al., 1989). In other words, for the cystic fibrosis population, 
Radtke and colleagues (2016) suggested if there were a change of five repetitions in the 
before and after tests, the clinical team would need to review the patient’s management plan. 
Segura-ortí et al. (2011) suggested the 1MSTST to be one of the reliable outcome measures 
for patients undertaking haemodialysis. The authors in this study had suggested a minimal 
clinical important difference of four repetitions. Lastly Simm et al. (2014) examined the 
efficacy of their pain management programmes using the 1MSTST. They have adopted the 
Segura-Orti et al. (2011) minimal clinical important difference of four repetitions in their 






COPD Assessment Test (CAT) 
Jones et al. (2009) developed the COPD Assessment Test (CAT) with the aim of creating an 
easy, but valid, life impact assessment tool for people living with COPD. Jones et al. (2009) 
identified eight stand-out themes from their qualitative research on people living with COPD 
and these eight themes formed the backbone of the CAT. The eight items identified were 
cough, phlegm, chest tightness, breathlessness, activities, confidence, sleep, and energy. 
Jones et al. (2009) then conducted analyses on differential functioning between countries, 
internal consistency, and tested the correlation of the CAT to the well validated St George’s 
Respiratory Questionnaire (SGRQ). Jones and colleagues (2009) had identified a strong 
correlation between the CAT and the COPD-specific SGRQ with r= 0.8 (p<0.0001) in the 
stable COPD patients and r= 0.78 in acute patients with exacerbation. The analyses and tests 
revealed the CAT was a short and simple, but at the same time sensitive and reliable, 
standardised measure for people living with COPD and it had worldwide relevance (Jones et 
al., 2009). The CAT was also examined by Kon et al. (2013) on patients who had other 
chronic respiratory conditions in the pulmonary rehabilitation setting. Their results suggested 
the CAT was as responsive to change in the non-COPD population when compared to the 
counterpart COPD population. Kon et al. (2014) established a minimal clinical important 
difference for the CAT. After studying 1,565 sets of paired CAT the authors suggested a 
change of 2 points to be clinically important, which in practice means a reduction of two 
points is considered to be a clinically important improvement and an increase of two points 
represents a clinically important deterioration (Kon et al., 2014). A copy of the CAT 
questionnaire is presented in Appendix C. 
Hospital Anxiety and Depression Score (HADS) 
The Hospital Anxiety and Depression Score (HADS) was used to monitor and assess the 
mental wellbeing of the patients. Zigmond and Snaith first developed the now well validated 
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HADS score in 1983 (Zigmond & Snaith 1983). It was initially developed to identify anxiety 
disorders and depression among patients visiting the non-psychiatric hospital clinics 
(Zigmond & Snaith 1983). Bjelland et al. (2002) undertook a literature review on the validity 
of the HADS. They examined 747 papers identified from the PsycINFO database and tested 
the papers based on three standardised questions on the validity and consistency of the 
HADS. They reported from the review both the sensitivity and specificity of the HADS were 
high and both had a range of 0.70 to 0.90, (Bjelland et al., 2002). The HADS tool appeared to 
be a good, if not excellent, case-finding assessment tool for anxiety disorder and depression 
(Bjelland et al., 2002). A Chinese cross-sectional case control study carried out by Lou et al. 
(2012) on 1,100 COPD patients found the prevalence for people living with COPD and 
depression was five times more than people living without COPD (35.7% vs. 7.2%). The 
results also showed people living with COPD and anxiety issues were over three times more 
prevalent than people living without COPD (18.3% vs. 5.3%). In Switzerland, Nowak et al. 
(2014) concurred with the findings reported in Lou et al. (2012) study. The results from their 
ongoing prospective observational cohort study on 259 COPD participants suggested the 
clinicians needed to be more aware of the significant higher prevalence of psychological 
comorbidities in people living with chronic respiratory illnesses. These findings all pointed 
towards the importance of screening people living with COPD for anxiety and depression 
symptoms, using the questionnaire (Nowak et al, 2014). A copy of the HADS questionnaire 
is presented in Appendix D. 
EQ-5D health-related quality of life questionnaire. 
EQ-5D quality of life score was also used in this research. The EQ-5D has shown to have the 
ability to measure the health of a population and detecting changes in the subgroups (Kind, 
Dolan, Gudex & Williams, 1997). The EQ-5D 3L used in this thesis project consists of two 
domains, the EQ-5D index and the EQ-5D visual analogue domains. The EQ-5D index 
domain consists of five general quality of life questions. These questions attempt to establish 
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the mobility, self-care, usual activity, pain/discomfort and anxiety/depression statuses of the 
person. There are three answers to each of the five aspects-of-life questions, the person either 
has no problems, some problems or a lot of problems in the area asked. The EQ-5D visual 
analogue domain attempts to determine how well or unwell the person feels about their health 
state by providing a zero to a hundred scale, with the zero end meaning the worst imaginable 
health state and the hundred, best imaginable health state. Pickard et al. (2008) conducted 
their study on validating the use of EQ-5D in people living with COPD and estimating a set 
of EQ-5D utility scores that could be linked to the different stages of COPD. The study’s 
results supported the use of EQ-5D in people living COPD. Pickard et al. (2008) suggested 
the EQ-5D scores could better inform the clinician on the wellbeing of the patient to allow 
better decision-making and resource allocation. Zanini et al. (2015) estimated a minimal 
clinical important difference to the EQ-5D visual analogue scale score (range from zero to 
100) for people living with COPD in a pulmonary rehabilitation setting. The authors have 
found a change of eight units out of a possible 100 units is considered to be clinically 
important. They had also found through the EQ-5D visual analogue, those people living with 
poorly managed COPD benefitted the most from attending a pulmonary rehabilitation 
programme (Zanini et al., 2015). A copy of the EQ-5D questionnaire and visual analogue 
scale (VAS) is presented in Appendix E. 
 
Summary. 
The home-based pulmonary rehabilitation programme had similar format to the Centre-based 
Pulmonary Rehabilitation Programme. The inclusion and exclusion criteria, assessment tools 
used, and most of the participant resources would be the same. The main differences will be 
in the recruitment component and the intervention content between the two programmes. In 
the home-based pulmonary rehabilitation programme the participants were not recruited from 
fresh referrals from the health professionals, the participants were re-discovered from the 
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decline and withdraw groups of the pre-existing pool of referrals. The home-based pulmonary 
rehabilitation intervention content contained one extra resource, the “Move on up” DVD. 
This addition was meant to offer the home-based pulmonary rehabilitation programme 
participants more opportunities to learn about their condition, which would otherwise have 
been shared and supported regularly in the centre-based pulmonary rehabilitation programme.  
In the next chapter, I discuss the result findings from the implementation of the methods 




Chapter 4: Results  
The results presented in this chapter examines firstly the demographic characteristics of the 
home based and centre based groups both descriptively and interpretively, secondly the 
intervention outcomes across both groups, and thirdly, the Patient Satisfaction Survey results. 
Demographic profile of the home based and centre based groups 
The before and after intervention data were collected over two two-week periods 
approximately two months apart. At both home visits (home based group) the participants 
completed the study questionnaires and the one-minute sit-to-stand test. The “before 
intervention” data sets were collected during the period of 8th to 19th December 2014. The 
“after intervention” data collection was done during the period of 23rd February to 9th March 
2015.  Of the original 75 participants, who were assessed and deemed suitable for the home-
based pulmonary rehabilitation programme, on initial telephone contact, 29 participants 
declined to participate in the home-based pulmonary rehabilitation (rate of decline 29/75 = 
39%). The reasons varied from ill health, other commitments to the patient did not wish to 
participate. The remaining 46 participants were offered a pre-programme assessment date. 
Unfortunately, 16 of these participants withdrew from the programme after the initial 
appointments were scheduled (16/46 declined = 35%). The reasons varied from ill health or 
to the patient not being at home at the agreed time of the visit. On a more positive note, two 
of the 16 participants who withdrew from the home-based pulmonary rehabilitation 
programme were re-referred to the centre-based pulmonary rehabilitation programme due to a 
change in their life or work situations.  
Altogether 30 participants started the home-based pulmonary rehabilitation programme. 
Seven participants withdrew from the programme for personal reasons and medical illnesses 
(7/30 = 23% failed to complete the programme. One of the seven died. A further two 
participants (2/23 = 9%) withdrew when contacted to make a post-programme assessment 
appointment, one had a bad viral flu and the other had surgery in the post-assessment week.  
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Hence a total of 21 patients completed the full home-based pulmonary rehabilitation 
programme, this is shown in Figure 12 below. 
As discussed in the Chapter on methods, a minimum of 63 centre-based patients from the 
database would be required to have a 1:3 home-based pulmonary rehabilitation programme: 
Centre-based ratio of participants in the research. Seventy control patients were randomly 
selected from the COPD health service database. The demographic profile of the study 
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Table 1. The demographic profile of participants at baseline
   Variable  home-based pulmonary 
rehabilitation 
programme  group 
Centre-based group 
Sample size  21 70 
    
Gender Male 11 (52%) 24 (34%) 
 Female 10 (48%) 46 (66%) 
    
Mean age in years  68.76 74.61 
    
Ethnicity NZ European/Pākehā 15 (71%) 52 (74%) 
 NZ Māori 3 (14%) 3 (4%) 
 European not otherwise 
specified 
2 (10%) 2 (3%) 
 Pacific Island 0 0 
 Asian 0 0 
 Other 1 (Dutch, 5%) 12 (3 other European, 9 
Other, 17%) 
 Not specified 0 1 (1%) 
    
Spirometry Mild (FEV1> 80% 0 2 (3%) 
 Moderate (50% < FEV1 < 
80%) 
5 (24%) 26 (37%) 
 Severe (30% < FEV1 < 
50%) 
11 (52%) 28 (40%) 
 Very Severe (FEV1< 
30%) 
4 (19%) 14 (20%) 
 No FEV1 data 1 (5%) 0 
    
CRQ (mean) Dyspnoea 14.2 15.8 
 Emotional Function 30.1 32.9 
 Mastery 18.7 19.1 
 Fatigue 13.7 15.8 
HADS (mean) Anxiety 7.0 6.6 
 Depression 5.6 5.0 
1MSTST (mean)  18.3 Did not perform 
CAT score (mean)  19.7 Did not perform 
EQ-5D (mean) Index 0.59 0.62 




Outcome analysis: baseline data 
The SPSS statistics programme was the main statistic tool used to analyse the data. The 
primary outcome measurements; the CRQ, HADS and EQ-5D, were tested for their normality 
by looking at their Q-Q plots, Kurtosis (lop-sidedness of the distribution), Skewness 
(peakedness or flatness) and Shapiro-Wilk values.  
In SPSS a Kurtosis range of +/- 1 reflects a very good normal distribution and +/- 2 reflects 
an acceptable normal distribution. The Skewness range is similar to the Kurtosis value. A 
value of zero suggests a symmetrical distribution, but values between +/-1 to +/-2 are 
considered to be acceptable. The Shapiro-Wilk test values were also referred to in 
determining the data sets’ degree of normal distribution (SPSS, 2015). For the purpose of this 
research and to be consistent with international studies, a p-value of <0.05 was considered 
statistically significant.  
The SPSS statistic software, contains the quantile-quantile plot or Q-Q Plot, which is a 
graphical method in determining whether the data is normally distributed.  A 45 degree 
reference line is drawn in the middle of the graph. If the data set is normally distributed, the 
values should fall approximately along the reference line. The collected data and the change 
values in this research project appeared to be following the linear reference line closely on 
the Q-Q Plot. These generated graphs are therefore suggesting that the collected values are 
likely to follow a normally distributed pattern. Below are two classic examples of the Q-Q 
Plot distributions in the analysed outcome values and presented in Figure 13, other Q-Q Plot 




Figure 13:   Examples of the Q-Q plot graphs generated from the data. 
 
The Kurtosis and Skewness values for the parameters were mostly within the acceptable 
range to suggest that the data followed a normal univariate distribution. The only two 
exceptions were the pre-programme depression value for the control centre based group and 
the pre-programme EQ-5D index value for the home based group. In the pre-programme 
values the Shapiro-Wilk test suggested the EQ-5D index value and CRQ mastery value of the 
home based group and the depression value, the EQ5D index and the CRQ dyspnoea value 
for the control group were not normally distributed. The Shapiro-Wilk test also suggested that 
the post-programme parameters, other than the anxiety and dyspnoea values, most of the 
control group values were not normally distributed. In the post-programme home based 
group, there were only two parameters, EQ-5D index and CRQ emotional function that were 
not normally distributed (p-value < 0.05).  
  
Normal Q-Q Plot of Pre Programme CAT score for the 
Intervention group 
 






Below Table 2 consisted the Kurtosis, Skewness and Shapiro-Wilk test values for the pre-
assessment and post-assessment and the change measured between the pre and post 
assessments. 
Table 2. Normality analyses to the parameters 
 









Pre programme Anxiety -.910/ -.631 .045/ .284 .616/ .127 
 Depression -.680/ 3.304* -.399/ 1.264 .075/ .000* 
 EQ5D Index 4.322*/ 1.163 1.473/ .586 .012*/ .000* 
 EQ5D Analogue -.331/ -.655 -.107/ -.224 .695/ .055 
 CRQ Dyspnoea .457/ .148 .813/ .742 .289/ .008* 
 CRQ Fatigue -1.214/ -.363 .286/ -.197 .097/ .211 
 CRQ Emotion .757/ -.961 .345/ .123 .880/ .085 
 CRQ Mastery -1.353/ -.158 -.342/ -.344 .032*/ .087 
     
Post programme Anxiety .969/ -.560 .097/ .309 .474/ .079 
 Depression .935/ -.052 1.018/ .726 .077/ .000* 
 EQ5D Index -.110/ .630 .273/ -.007 .028*/ .000* 
 EQ5D Analogue -.891/ -.287 -.240/ -.492 .590/ .018* 
 CRQ Dyspnoea -.788/ -.766 -.208/ .114 .616/ .194 
 CRQ Fatigue -1.222/ -1.088 -.170/ -.254 .146/ .007* 
 CRQ Emotion .836/ -.978 -1.143/ -.363 .016*/ .007* 
 CRQ Mastery -.970/ -.381 -.364/ -.675 .185/ .001* 
     
The Change Anxiety 2.128*/ .519  .866/ .368 .067/ .097 
 Depression .082/ .426 -.178/ .512  .484/ .006* 
 EQ5D Index -.633/ .324 -.134/ .278 .583/ 0.004* 
 EQ5D Analogue .263/ 2.718* -.189/ 1.165 .326/ .000* 
 CRQ Dyspnoea -.153/ -.066 .030/ .235 .936/ .865 
 CRQ Fatigue -.509/ .261 -.318/ .287 .543/ .279 
 CRQ Emotion .200/ 1.104 -.986/ .950 .036*/ .002* 
 CRQ Mastery .074/ -.593 .681/ -.124 .235/ .185 
* significance level p<0.05 
Based on these findings I decided to carry out both the parametric and non-parametric tests to 
examine the null hypothesis that there is no significant difference (p-value <0.05) between 
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the home-based pulmonary rehabilitation programme and the centre-based pulmonary 
rehabilitation programme  groups in the CRQ scores and the secondary outcome measures 
(1MSTST, CATS, HADS and EQ-5D). 
The two groups showed no significant difference in gender distribution or mean age. The 
home based group had an almost equal proportion of male and female participants (11:10, 
52%: 48%), whereas the control centre based group had 24 males and 46 females (34%: 
66%), as illustrated in Figure 14, and while this difference was not statistically significant it 
is worth noting that proportionally more males attended the home-based pulmonary 
rehabilitation than the centre-based pulmonary rehabilitation. 
 
Figure 14. The gender distribution of the Control and Intervention groups. 
 
The Chi square test was chosen to analyse the gender data of the intervention (home-based 
pulmonary rehabilitation programme) and control (centre-based pulmonary rehabilitation 
programme) groups due to the fact that gender is a categorical variable. The 2-sided Pearson 
Chi square value suggested no statistical difference in gender between the two groups with 






























However, it was a different scenario for the age distribution. The mean age of the 
intervention group was 68.8 years of age, almost 6 years younger than the control group (74.6 
years of age), as illustrated in Figure 15..  
 
Figure 15. The age distribution in age range groups in the Control and Intervention groups. 
 
A t-test was performed on the age data, assuming the age data set was normally distributed, to 
determine if there was any statistical significant difference between the two groups. The 2-
tailed t-test suggested statistical significant difference in the mean age between the two 


































The ethnicity distribution was similar across both groups. The majority of the participants 
identified themselves as New Zealand European, 71% in the intervention group and 74% in 
the centre based control group. However, the intervention group had a higher representation 
from the Māori community, although there were 3 Māori participants in each group, as 
illustrated in Figure 16.  
 
Figure 16. The ethnicity distribution in the control centre based pulmonary rehabilitation and 
the intervention home based pulmonary rehabilitation groups. 
 
Once again, due to the categorical variable nature of the ethnicity data, the Chi square test 
was performed to determine if there was any statistical difference between the two groups. 
The 2-sided Pearson Chi square test suggested no statistical significant difference between 
the two groups in regards to the ethnicity distribution with X2= 11.335, p > 0.05.  The forced 
expiratory volume in one second or FEV1 in the spirometry testing determined the severity of 
the participants’ breathing condition. Both groups appeared to have similar mean FEV1 
values at baseline. The control group had a mean FEV1 of 45% predicted value and the 


































classified as having severe airflow obstruction, or GOLD Stage III COPD (FEV1 value 
between 30-50%). From the demographic data the moderately to severely obstructed patients 
were the majority in both groups (intervention group, 76%; control group, 77%); the very 
severely obstructed participants constituted approximately 20% of both groups. It is also 
interesting to note that the intervention group appeared to have a higher proportion of the 
severely obstructed participants compared to the participants in the control group (52% vs 
40%), as illustrated in Figure 17.  
 
 
Figure 17. The severity of airway obstruction distribution in the Control and Intervention 
groups. 
 
A t-test was performed on the FEV1 data, assuming the FEV1data set was normally 



















groups. The 2-tailed t-test suggested no statistical significant difference in FEV1 mean scores 





Summary of demographic characteristics of the participants 
 
 The data suggest that the centre based (control) group programme (Centre-based) was 
better attended and tolerated by female participants than male participants, to the ratio of 
2:1. The home based (intervention) group (those following the home-based pulmonary 
rehabilitation programme and was able to reach an almost equal representation from both 
male and female patients.  
 The mean age for the intervention group was younger than the control group by almost 6 
years. The intervention group had the largest participant proportion at the 60-69 years of 
age subgroup, whereas the control group had the largest participant proportion at the 70-
79 years of age subgroup.  
 The Pulmonary Rehabilitation Programme participants were mostly New Zealand 
Europeans in both the intervention and control groups which represents the ethnic 
composition of the community they were recruited from. The intervention group was 
close to four times more effective in reaching out to the New Zealand Māori community 
when compared to the control group.  
 The severity distribution between the home based and centre based groups appeared to 
be similar. It is worth noting, however, that the control group participants had a very 
gradual peak at the severely obstructed subgroup when compared to the centre based 




The primary outcome measure 
The Chronic Respiratory Questionnaire (CRQ) results 
 
The Chronic Respiratory Questionnaire is a reliable and validated questionnaire used to 
assess and analyse the quality of life of people living with chronic respiratory conditions 
(Guyatt et al., 1987). The questionnaire has four main categories derived from 20 questions 
that relate to dyspnoea, emotion, mastery, and fatigue. Please refer to the Chapter on methods 
for the more detailed explanation of the CRQ. The response totals to each of the CRQ 
domains were calculated before analysis. De Torres and colleagues note that a change in the 
mean score of plus/minus two (the effect size) from the pre-assessment and post-assessment 
is considered to be of clinical significance (2002). A higher value in the questionnaire means 
better management (a plus change score) and a lower value means poorer management (a 
minus change score). 
The dyspnoea data, which measured how much the participants felt breathlessness was 
affecting their lives, suggested before any intervention was put in place both groups appeared 
to have a similar level of breathlessness a higher mean score of 15.8 in the centre based 
control group compared to the lower mean score 14.2 in the intervention group. These values 
were out of a highest possible total score of 35 and the higher the score the better one feels 
about the level of breathlessness. At the end of the programmes, both groups’ participants 
demonstrated improvements more than the minimal clinically significant difference (two 
points) on the scale. It is worth noting that people from the home-based pulmonary 
rehabilitation group appeared to have more dyspnoea symptoms compared to the centre-
based pulmonary rehabilitation group. The result of this measure implied that both 
intervention methods were clinically effective; however, no one intervention was more 




Figure 18. The CRQ dyspnoea mean values pre and post programme for the Control and 
Intervention groups. 
 
The mean change difference values were calculated and analysed using the SPSS tool for 
both groups. The mean change difference values were then put through the parametric t-test 
and the non-parametric Mann-Whitney and Wilcoxon statistical analysis to determine if there 
were any significance between the change in the control group and the intervention group. In 
the centre-based pulmonary rehabilitation, the dyspnoea mean change value was 4.62 (ranged 
from -9 to 22) and in the home-based pulmonary rehabilitation the mean change value was 
4.08 (ranged from -11 to 17). Both 2-tailed analyses revealed that the mean difference 
achieved in the home-based pulmonary rehabilitation group had no statistical significant 
difference to the centre-based pulmonary rehabilitation group with t = -0.336, p > 0.05; non-
parametric test z = -0.310, p> 0.05. Both groups had achieved a statistical and clinically 
significant improvement (change value > 2) in this CRQ category (home-based pulmonary 

















6.135, p< 0.05). The centre-based pulmonary rehabilitation group had increased mean score 
by 4.6 points (doubled the minimal clinically significant value) and the home-based 
pulmonary rehabilitation group had a mean improvement value of 4.1 points. The centre-
based pulmonary rehabilitation group appeared to have performed marginally better by 0.54 
points than the home-based pulmonary rehabilitation, however the difference was 75% below 
the clinically significant two-point change required and statistically no significant difference 
was identified. These analyses suggest that the home-based pulmonary rehabilitation 
intervention is just as clinically effective as the centre-based pulmonary rehabilitation, the 
routine practice when managing dyspnoea. 
In the emotional function category, which measured how the participants were coping 
emotionally with their breathing conditions, it followed a similar pattern to the dyspnoea 
category. The highest possible total for the emotional function category is 49 and once again 
the higher the score the better the user feels about his emotional function. There was no 
statistical difference at baseline between the centre-based pulmonary rehabilitation and home-
based pulmonary rehabilitation groups, with t = -1.412, p> 0.05, hence both groups were 
similar in emotional function at baseline. The centre-based pulmonary rehabilitation 
participants did have a slightly better emotional function, with a higher mean scores at both 
the start and the end of the programme (32.7 vs. 30.1; 37.2 vs. 34.3), when compared to the 
home-based pulmonary rehabilitation group. At the conclusion of the programmes, the mean 
value in both groups suggested a clinically significant improvement with no statistical 




Figure 19. The CRQ emotional function mean values pre and post programme in the Control 
and Intervention groups. 
 
The mean change difference values for the emotional function were calculated and analysed 
using the SPSS tool for both groups. The mean change difference values were then put 
through the parametric t-test the non-parametric Mann-Whitney and Wilcoxon statistical 
analysis to determine if there were any significance between the change in the centre-based 
pulmonary rehabilitation group and the home-based pulmonary rehabilitation group. In the 
centre-based pulmonary rehabilitation, the emotional function mean change value was 4.31 
(ranged from -10 to 25) and in the home-based pulmonary rehabilitation, the mean change 
value was 4.23 (ranged from -17 to 16). Similar to the dyspnoea category, both analyses 
showed no statistical significant difference (t = -0.044, p< 0.05) between the centre-based 
pulmonary rehabilitation and the home-based pulmonary rehabilitation groups. There were 
clinically significant improvements in the emotional function category for both groups, and 
paired t testing also revealed both groups had achieved statistically significant improvement 
with centre-based pulmonary rehabilitation t = -5.260, p< 0.05 and home-based pulmonary 

















to increase the emotional function value by 4.3 points whereas the home-based pulmonary 
rehabilitation 4.2 points. By taking into account that a clinical important difference was 
defined as 2 points, the centre-based pulmonary rehabilitation group performed better by 0.1 
point, but the actual clinical importance would be insignificant. This result also suggests that 
the home-based pulmonary rehabilitation was no worse than the control, centre-based 
programmes when managing participants’ emotional function.  
In the mastery category, which measured how much the participants felt they were in control 
of their breathing conditions, there were similar trends to the previous two categories. The 
SPSS analysis did not suggest any statistical difference at baseline between the centre-based 
pulmonary rehabilitation and home-based pulmonary rehabilitation groups with t = -0.297 
and p> 0.05. The centre-based pulmonary rehabilitation group appeared to have slightly more 
confidence in managing their own breathing condition at baseline, but one could argue that 
the 0.4 point difference in the mean value was minimal, considering 0.4 point is only 20% of 
the clinically important level of 2 points. Both groups appeared to have low mastery levels to 
their breathing conditions at baseline which was expected for this patient group. At the 
conclusion of the programmes, both groups’ mean values were able to achieve clinically 
significant improved outcomes with no statistically significant difference between the two 
groups. The paired t tests showed the improvement made by both the centre-based pulmonary 
rehabilitation and home-based pulmonary rehabilitation groups were statistically significant, 
centre-based pulmonary rehabilitation t = -5.560, p< 0.05 and home-based pulmonary 
rehabilitation t = -3.311, p <0.05. The highest possible score for the mastery category is 28, 




Figure 20. The CRQ mastery mean values pre and post programme in the Control and 
Intervention groups. 
 
The mean change difference values were calculated using the SPSS statistics software for 
both groups. The mean change difference values were then put through the parametric t-test 
and the non-parametric Mann-Whitney and Wilcoxon statistical analysis to determine if there 
were any significance between the change in the centre-based pulmonary rehabilitation group 
and the home-based pulmonary rehabilitation groups. In the centre-based pulmonary 
rehabilitation the mastery mean change value was 3.07 (ranged from -9 to 12) and in the 
home-based pulmonary rehabilitation the mean change value was 3.24 (ranged from -4 to 
13). Similar to the dyspnoea and emotional function categories, both analyses showed no 
statistically significant difference (t = 0.146, p> 0.05) between the centre-based pulmonary 
rehabilitation and the home-based pulmonary rehabilitation groups. This result indicates that 
the home-based pulmonary rehabilitation intervention was as effective as the centre-based 
pulmonary rehabilitation programme in improving participants’ mastery level in managing 

















The Fatigue category measures the amount of tiredness the participants felt that their 
breathing condition was affecting their lives in general with a highest possible total score 
being 28 representing the participant felt they had complete control over their level of fatigue. 
The baseline measurement revealed that both groups were comparable, with t = -1.727, p> 
0.05. Once again the fatigue level in the centre-based pulmonary rehabilitation group 
appeared to have clinically significant better fatigue management at baseline when compared 
to the participants in the home-based pulmonary rehabilitation group, with a difference of 2.1 
points (15.8 vs. 13.7). The mean values suggested that participants in both groups were able 
to achieve improvement in this category, which are results that are similar to the other CRQ 
categories. The centre-based pulmonary rehabilitation had made a 3.1 point clinically 
significant improvement and the home-based pulmonary rehabilitation group had made an 
improvement of 1.7 points, 0.3 points below the 2-point change required to achieve the 
clinically significant level. The statistical analysis confirmed the clinical interpretation with 
the centre-based pulmonary rehabilitation group and showed statistically significant 
improvement t= -5.647 p< 0.05, but not in the home-based pulmonary rehabilitation group 
with t= -1.503 p> 0.05. In terms of fatigue, the centre-based group performed better than the 
home based group, hence where fatigue is an important factor in a patient’s self-management 
of COPD, providing and encouraging the participation in the centre-based pulmonary 
rehabilitation is preferable than providing the home-based pulmonary rehabilitation option, 
although the home-based pulmonary rehabilitation group were on average more fatigued at 
baseline compared to the centre-based pulmonary rehabilitation group, as illustrated in Figure 




Figure 21. The CRQ fatigue mean values pre and post programme in the Control and 
Intervention groups. 
 
The mean change difference values were calculated and analysed using the SPSS tool for 
both groups. The mean change difference values were then put through the parametric t-test 
and the non-parametric Mann-Whitney and Wilcoxon statistical analysis to determine if there 
were any statistical significance between the change in the control group and the intervention 
group. In the centre-based pulmonary rehabilitation the fatigue mean change value was 
calculated to be 3.04 (ranged from -7 to 15) and in the home-based pulmonary rehabilitation 
the mean change value was 1.66 (ranged from -8 to 10). This is similar to the other CRQ 
categories, where neither of the analyses showed any statistically significant difference, 
t=-.195, p<0.05, between the centre-based pulmonary rehabilitation and the home-based 
pulmonary rehabilitation groups in the fatigue mean change values. This result indicates that 
the home-based pulmonary rehabilitation was as equally effective in assisting participants to 
achieve positive change in the fatigue management category when compared to the centre-

















more superior statistically and clinically significant improvement when compared to the 
home-based pulmonary rehabilitation programme. 
 
The secondary outcome measures: 
The HADS results 
Hospital Anxiety and Depression Score (HADS) is used to monitor and assess the mental 
wellbeing of the patients. This is a very widely used assessment tool in research worldwide 
when looking into the anxiety and depression levels of the patients. Lou et al. note that people 
living with chronic medical conditions have higher anxiety and depression levels compared to 
a healthy population (2012). The Chapter on methods provides a more detailed explanation of 
the HADS. 
In both the home-based pulmonary rehabilitation and the centre-based pulmonary 
rehabilitation groups, the mean values before the programmes started were similar. The 
independent t-test indicates that at baseline, there were no statistical differences between the 
centre-based pulmonary rehabilitation and home-based pulmonary rehabilitation groups in 
their mean anxiety and depression levels. In the anxiety domain, t = 0.287, p>0.05 and in the 
depression domain, t = 0.842, p>0.05. In the centre-based pulmonary rehabilitation group, on 
average, patients had an anxiety score of 6.7 out of a total highest possible value of 21 and a 
depression score of 5 out of a highest possible total of 21. In both domains, the higher the 
score, the worse the symptoms would be. These values are compared to an anxiety mean 
value of 7, a 0.3 point difference, and a depression value of 5.6, a 0.6 point difference, in the 
home-based pulmonary rehabilitation group. In other words, at baseline, both groups had 




Figure 22. The HADS Pre Programme mean values in the Control and Intervention groups. 
 
The HADS was measured again in both groups at the conclusion of the eight-week 
programmes. In the centre-based pulmonary rehabilitation group, the mean value for anxiety 
was 5.5 and for depression was 3.7. For the home-based pulmonary rehabilitation group, 6.7 
was the mean value for the anxiety component and 5 for the depression component. No 
statistical differences were identified between the two groups on conclusion of the 
programmes with t = 1.646, p>0.05 in the anxiety domain and t = 1.897, p> 0.05 in the 


















Figure 23. The HADS Post Programme mean values in the Control and Intervention groups. 
 
The 2-tailed t-test was used as the main parametric analysis tool to examine the differences 
between the post-programme scores and pre-programmes scores. For the non-parametric 
analysis, a 2-tailed significance value was generated using the Mann-Whitney and Wilcoxon 
tests. Both parametric and non-parametric tests were used based on the results of the normal 
distribution analysis, which suggested the centre-based pulmonary rehabilitation group 
depression values were not following a normal univariate pattern. The analysis also had 
indicated that the difference between the post-programme and pre-programme anxiety values 
in the intervention group may not follow a normal univariate distribution.  
Both the parametric and non-parametric analyses showed the mean change difference scores 
between the home-based pulmonary rehabilitation and centre-based pulmonary rehabilitation 
groups were not statistically significant, t = -1.250, p> 0.05 in the anxiety domain with 
centre-based pulmonary rehabilitation mean change value of 1.10 (ranged from -5 to 14) and 

















= -1.1.60, p> 0.05 in the depression domain with centre-based pulmonary rehabilitation mean 
change value of 1.25 (ranged from -4 to 7) and home-based pulmonary rehabilitation mean 
change value of 0.52 (ranged from -5 to 6). The before and after paired t-test for the centre-
based pulmonary rehabilitation group indicated a statistically significant improvement in both 
the anxiety and depression domains, t= 3.276, p<0.05 and t =4.172, p< 0.05 respectively. The 
home-based pulmonary rehabilitation pre and post HADS outcomes were not statistically 
significant, for the anxiety domain (t = 0.404, p > 0.05) or in the depression domain (t 
=0.937, p> 0.05), and therefore there were no clinical improvements in these domains for the 
CBRP group. These outcomes illustrated that both home-based pulmonary rehabilitation and 
the centre-based pulmonary rehabilitation group, for managing anxiety and depression levels 
in people living with COPD, achieved change in the expected direction. In the centre-based 
pulmonary rehabilitation group, however, the change was greater than that experienced in the 
home-based pulmonary rehabilitation group. 
The 1-minute sit-to-stand test 
As mentioned in the chapter on methods, the 1-minute sit-to-stand test (1MSTST) is a fast 
and practical test to assess a participant’s exercise capacity. The pulmonary rehabilitation 
service only started to use this exercise capacity test recently, and therefore, I was unable to 
obtain any 1MSTST historical data for the home-based pulmonary rehabilitation (control) 
group to compare to the HBRP group in this category. Altogether there were 19 completed 
1MSTST data sets from the home-based pulmonary rehabilitation group, which included a 
pre-programme and a post-programme score. Radtke et al. (2016) states that the test has an 
estimated minimal detectable difference value of 5 in 1MSTST for the cystic fibrosis 
population. Simm et al. (2014) used a minimal detectable change value of 4 in 1MSTST for 
the participants in the pain management programme. For the purpose of this study, a change 
value of 5 is the minimal detectable difference value (clinically significance change), because 
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the people who attend the pulmonary rehabilitation programmes would have more 
resemblance symptomatically to people living with cystic fibrosis than people living with 
chronic pain. 
 
Figure 24. The 1MSTST change values for the intervention group. 
 
Only three out of the 19 participants (16%) had achieved a detectable change in the 1MSTST, 
as illustrated in Figure 24. The participants in the intervention group had a mean 1MSTST 
score of 18.3 at the beginning of the programme and 18.1 at the conclusion of the programme 
with a mean change statistical significant difference between the pre-programme and post-
programme outcome of -0.2 repetition. The paired t-test also showed that there was no 
values, with t = 0.664, p> 0.05. These statistics were compared to the draft year 2013-2015 
Pulmonary Rehabilitation Outcome Report (CCN Community Pulmonary Rehabilitation 
Services, 2015). In the community pulmonary rehabilitation programmes, the report 
described 36% of the 152 participants had achieved a detectable change with the mean pre-
programme 1MSTST score of 17.8 and 20.4 at the conclusion of the programme, a mean 
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rehabilitation programmes were better in improving participants’ fitness level, although the 
patients in the report may have differed from other aspects from the patients in the HBRP, 




The COPD assessment tool (CAT) score 
The CAT score is an 8-statement based questionnaire. As mentioned in the chapter on 
methods, the CAT score is a practical way to measure the impact of COPD on the 
participant’s wellbeing in general. This is a useful tool for the participant and the health 
professional to determine whether there is a need to implement extra strategies to maximise 
the effect of the medical treatments and self-management plans (Jones et al., 2009). Like the 
1MSTST this assessment tool had only recently been introduced to the pulmonary 
rehabilitation service and I was unable to obtain historical data for the home-based 
pulmonary rehabilitation group to compare to. 
 
Figure 25. The CAT score change values for the intervention group. 
 
There were 21 participants who had completed the pre-programme and post-programme CAT 
scores. Eleven out of 21 participants (52%) achieved a clinically significant improvement, as 
illustrated in Figure 25. The mean baseline value was 19.7 and the mean post-intervention 
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majority of the home-based pulmonary rehabilitation group having achieved a clinically 
significant improvement, the pre-programme and post-programme home-based pulmonary 
rehabilitation CAT score values were unable to achieve statistical significant improvement 
when analysed using paired t-test, t = 0.298, p>0.05. These statistics were compared to the 
draft year 2013-2015 pulmonary rehabilitation outcome report (CCN Community Pulmonary 
Rehabilitation Services, 2015). In the community pulmonary rehabilitation programmes 
report 48% of the 191 participants had achieved a clinically significant change with the mean 
pre-programme CAT score of 19.3 and 18.1 at the conclusion of the programme, a mean 
change of -1.1 to the score. At a glance, both the home-based pulmonary rehabilitation and 
centre-based pulmonary rehabilitation were as effective in supporting the participants to 
achieve a clinically significant improvement, although for the HBRP group this improvement 
was not statistically significant.  
EQ-5D 
The EuroQol Group’s 5-dimension questionnaire (EQ-5D), described in the Chapter on 
methods, is a commonly used questionnaire internationally to measure health-related quality 
of life (HRQOL) (Zanini et al, 2015). Unfortunately, the historical EQ-5D data set for the 
centre-based group was incomplete. The database only recorded the overall EQ-5D index 
score not the individual domain scores, which would be required for detailed analysis. For 
this study, therefore, I will look at the overall EQ-5D index, EQ-5D visual analogue scale 
(VAS) and the comparison between the two groups to get some understanding of the changes 
made in participants’ quality of life. Zanini et al. (2015) suggested for the moderate-to-severe 
COPD participant a change of 8 units or greater on the EQ-5D VAS (equivalent to 0.8 and 
greater in this study) to be the minimal clinically important difference. For the EQ-5D index, 
Pickard et al. (2008) reported reference values for the people living with COPD according to 
the different stages of COPD. 
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In the intervention group, 13 out of the 21 participants (62%) had made a positive shift in 
their EQ-5D indices compared to 35 out of 68 participants (51%) in the centre based control 
group. The mean baseline EQ-5D indices for the intervention and control groups were 0.59 
and 0.62 respectively. These values were compared to the pooled mean utility reference 
values suggested by Pickard et al. (2008). The mean forced expiratory volume during the first 
second (FEV1) values from both groups (45% for the control and 41% for the intervention 
group) indicated that the participants had severe air obstruction or Stage III COPD (FEV1 
value between 30-50%). Stage III COPD has an EQ-5D pooled mean utility reference value 
of 0.69 (0.60-0.78) (Pickard et al, 2008). This indicated, before the participants started the 
pulmonary programme, that the quality of life index for participants in the intervention group 
was below the reference range and pooled mean value. The mean for the participants in the 
control group was just within the reference range but below the mean utility reference value 
for Stage III COPD population. The values were corrected once the participants completed 
the programme. In the home-based pulmonary rehabilitation group the mean value was 
improved to 0.64 and 0.68 for the centre based group. This indicates that participation in both 
groups was effective in elevating the participant’s quality of life level, noting that the control 









Figure 27. The Pre and post EQ-5D index values for the control group 
 
The EQ-5D VAS also presented similar trends in both the intervention and control groups. 
Ten out of the 20 participants (50%) in the intervention group and 33 out of 61 (54%) were 
able to make a positive shift on the VAS. The control group had a mean baseline VAS value 
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control group had an improved mean VAS value of 6.2 compared to 7.33 in the intervention 
group, and a mean change value of 0.35 and 0.66 for the control and intervention groups, 
respectively. The mean change values were below the Zanini et al. (2015) estimated and 
recommended minimal clinically important difference of 0.8 points. After attending the 
programme, however, the majority of the participants felt their quality of life had either been 
maintained or improved. It was encouraging to know that 8 (40%) participants in the 
intervention group and 26 (42%) in the control group had achieved the minimal clinically 
important difference threshold. Statistical analysis revealed the centre-based pulmonary 
rehabilitation group was able to achieve significant improvement in both the index (t = -
3.021, p< 0.05) and VAS (t = -2.908, p< 0.05) domains. Unfortunately, the same was not able 
to be replicated in the home-based pulmonary rehabilitation group with the EQ-5D index (t = 
-0.979, p> 0.05 and VAS t = -0.746, p>0.05). These results are illustrated in Figures 28 and 
30. 
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Figure 29. The EQ-5D VAS change values for the intervention group. 
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Figure 31. The EQ-5D VAS change values for the control group. 
 
The change values between the centre-based pulmonary rehabilitation and the home-based 
pulmonary rehabilitation group were analysed using SPSS. The tests revealed that there was 
no statistically significant difference between the two groups. In the EQ-5D index the centre-
based pulmonary rehabilitation had a mean change value of 0.05 (ranged from -0.3 to 0.39) 
and home-based pulmonary rehabilitation mean change value of 0.05 (ranged from -0.37 to 
0.39) with a calculated t= -0.196, p>0.05; z = -0.180, p> 0.05.The centre-based pulmonary 
rehabilitation EQ-5D VAS had a mean change value of 1.02 (ranged from -4 to 10) and home-
based pulmonary rehabilitation mean change value of 0.57 (ranged from -4 to 5) with a 
calculated t= -0.786, p. 0.05; z = -0.227, p>0.05. Both the parametric and non-parametric tests 
were carried out due to the fact that not all results collected from the EQ-5D had a univariant 
distribution. In summary the results suggested that the intervention group, the home-based 
pulmonary rehabilitation, performed no worse than the control (centre-based) pulmonary 




















Summary of results: 
 
 CRQ dyspnoea: the home-based pulmonary rehabilitation group was no worse than the 
control (centre-based) group. 
 CRQ emotional function: the home-based pulmonary rehabilitation group was no 
worse than the control group. 
 CRQ mastery: the home-based pulmonary rehabilitation group was no worse than the 
control group 
 CRQ fatigue: the home-based pulmonary rehabilitation groups was no worse in 
making clinically significant improvement when compared to the control group; 
however the control group had a significantly superior fitness level or fatigue 
management on post-assessment when compare to the home-based pulmonary 
rehabilitation group 
 HADS: home-based pulmonary rehabilitation provided anxiety and depression 
management which was statistically no worse than the control group. 
 1MSTST: The control group appeared to do better at improving the participants’ level 
of fitness when compared to the home-based pulmonary rehabilitation group. 
 CATS: the home-based pulmonary rehabilitation appeared to be no worse in helping 
the participants to learn how to effectively manage their breathing conditions when 
compared to the control group. 
 EQ-5D: the home-based pulmonary rehabilitation appeared to be no worse in 
improving participant’s quality of life; however, the centre-based pulmonary 
rehabilitation group had achieved significantly better outcomes when compared to the 
home-based pulmonary rehabilitation group. 
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The next chapter discuss the results presented in this chapter with reference to the study 
objectives and hypotheses. I also explore further the results in this study with current literature 






Chapter 5: Discussion 
Introduction 
Pulmonary rehabilitation is the back bone to this thesis and a well evidence-based practice to 
treat people living with chronic respiratory illnesses. In the literature review the research 
evidence had suggested that pulmonary rehabilitation is effective in improving patients’ self-
management skills by improving their breathing patterns, exercise capacity, and reducing the 
social isolation the chronic illnesses created. The home-based pulmonary rehabilitation was 
instigated due to the low referral and low completion rates within the centre-based pulmonary 
rehabilitation programme in the Canterbury region. This thesis examined the hypotheses that 
the home-based pulmonary rehabilitation would perform no worse than the centre-based 
pulmonary rehabilitation in the CRQ category and result in an objective improvement in the 
sit-to-stand test that is no worse than the centre-based pulmonary rehabilitation. The data 
analysis has confirmed that the home-based pulmonary rehabilitation is no worse than the 
centre-based pulmonary rehabilitation in all categories of the CRQ in achieving 
improvements; however, the home-based pulmonary rehabilitation was unable to outperform 
the centre-based pulmonary rehabilitation in the sit-to-stand test, and the exercise capacity 
test. These findings and conclusions must be interpreted with the project’s limitations and 
context in mind. 
The thesis findings are appraised with reference to current literature and evidence. The 
applications and implications of these research findings are multifaceted. The findings are 
approached from the patient journey perspective, looking at the objective measures and 
determine whether the home-based pulmonary rehabilitation was able to generate the 
hypothesised effects to these people living with chronic respiratory conditions at home. The 
findings are also examined from the providers’ perspective: a change of delivery model, the 
time and costs invested into this new model of delivery, and whether it is sustainable and 
economical to have home-based pulmonary rehabilitation as a permanent option within the 
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community pulmonary rehabilitation services. Lastly, the findings are also be assessed from 
the broader health system angle: is there a demand for such a home-based alternative?  
At this point, it is important to remember that the participants in the home-based pulmonary 
rehabilitation had already refused or declined offers to participate in the centre-based 
pulmonary rehabilitation programmes. If the home-based pulmonary rehabilitation 
programme were not put in place and offered to this group of participants, they would not be 
involved in any pulmonary rehabilitation services. In other words, the centre-based approach 
has already failed for the cohort of participants who were part of this home-based 
programme, and therefore the playing field is already not even. The consequences of such 
disconnect from health services could lead to a poorer quality of life and worse health 
outcomes. 
Overview 
The home-based pulmonary rehabilitation was able to deliver an effective intervention to 
people living with COPD. The majority of the outcome measures used in the study had 
shown the effects of home-based pulmonary rehabilitation were no worse than the centre-
based pulmonary rehabilitation, except for the CRQ fatigue and EQ-5D scores where home-
based pulmonary rehabilitation participants performed worse when compared to the centre-
based pulmonary rehabilitation participants. Overall, the home-based pulmonary 




The demographic analyses identified some interesting findings with regards to patient 
participation in pulmonary rehabilitation programmes. First, the analysis suggested the home-
based pulmonary rehabilitation was better at retaining male participants. In the home-based 
pulmonary rehabilitation group, we had a male to female participant ratio of roughly 1:1 
(52% and 48%), compared to 34% of male participants to 66% female participants in the 
control group centre-based pulmonary rehabilitation, which is about 1:2 in ratio. This 
interpretation must be viewed with the following considerations in mind. In 2013, the 
community pulmonary rehabilitation data was fully moved to an electronic system, MedTech. 
To date (December 2016), of all the referrals with gender status clearly stated, there is a total 
of 2,248 referrals received in the last three years, inclusive of the home-based pulmonary 
rehabilitation referrals (Canterbury Clinical Network, December 2016). The data indicated 
56% of the referrals were females and 44% were males. Puhan et al. (2005), carried out a 
systemic review on the effects of pulmonary rehabilitation on hospital admission and 
mortality to people with acute exacerbation of COPD. The randomised controlled trials 
included had mostly shown a male-dominant (five out of six studies) phenomenon, ranging 
from 41% to 90% male participants.   
The latest 2013 New Zealand Census (Statistics New Zealand, 2016) indicated the total 
population in the Canterbury region was 539,436, with 266,349 males and 273,087 females. 
These values equate to 49% of the Canterbury population were males and 51% were females. 
In other words, the centre-based pulmonary rehabilitation male and female gender 
distribution appeared to be in line with the referral trends but did not reflect the actual gender 
profile in the Canterbury region, where there are about equal proportion between the genders. 
Until recently the World Health Organisation (WHO) identified COPD as affecting more men 
than women; however, with the recent increase in tobacco use among women in high income 
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countries and more frequent exposure to other high risk contaminants among women, the 
disease is now affecting men and women in an almost equal proportion (WHO, 2016). The 
home-based pulmonary rehabilitation appeared to have the ability to correct the male to 
female referral imbalance, to reach out to an almost equal representation from the both 
genders, or in other words, to attract males to the home-based pulmonary rehabilitation, who 
refused invitation to attend the centre-based pulmonary rehabilitation.  
The male health utilisation pattern should also be considered in the interpretations of the 
lower male pulmonary rehabilitation referral and pulmonary rehabilitation attendance rates. 
Misan (2013) mentioned in his document that males were 15% less likely to visit a GP when 
compared to their female counterpart in a 12-month period (Misan, 2013). Britt et al. (2012) 
in their data on general practice activity in Australia between the years 2011 to 2012 also 
commented on lower health service utilisation in the male population. The report indicated 
that during the 12-month period, there were 43,000 GP encounters with males, which 
accounted for only 43% of the total GP consultations (Britt et al., 2012). Another paper by 
Schlichthorst et al. (2016), looking at factors associated with the healthcare utilisation by 
Australian men, found that the majority of men (61%) did not have regular health check-up 
visits in a 12-month period of time. The authors explained further the lack of regular primary 
health consultations may lead to lost opportunities in early detection and intervention for 
men, thus producing poorer health outcomes for men in general (Schlichthorst et al., 2016). 
The above findings would be of no surprise to the Canterbury pulmonary rehabilitation 
service providers. The pulmonary rehabilitation database (CCN, 2016) identifies that in 2015, 
the majority (59%) of the Canterbury pulmonary rehabilitation referrals were generated from 
the GP practices. If men are 15% less likely to go and see a GP and 61% of men did not have 
regular health check-ups, then assuming the target (Canterbury, New Zealand) male 
population has the same health utilisation rate as elsewhere suggests, we can infer that men 
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have missed out on being detected early and referred to the pulmonary rehabilitation service 
by as much as 61%. This can be one of the main explanations for the lack of male referrals 
and participants to the pulmonary rehabilitation services. 
The second interesting finding from this research project was the mean age for people 
participating the intervention group (the home-based pulmonary rehabilitation) was 
significantly younger, by almost six years, when compared to the participants in the control 
group (the centre-based pulmonary rehabilitation). The data indicated that the mean age for 
the home-based pulmonary rehabilitation group was 68.76 years and for the centre-based 
pulmonary rehabilitation, the mean age was 74.61 years of age. In most of the international 
literature, the mean age range for the pulmonary rehabilitation participants was between 65 to 
70 years of age (Schroff et al., 2017; Dodd et al., 2011; Eaton et al., 2009). In a recent paper 
by Schroff et al. (2017), the authors included 229 participants living with COPD who were 
enrolled in the pulmonary rehabilitation at the University of Alabama at Birmingham, U S 
from 1996 to 2013. The mean age was 66.5 years, 40% of the participants were females and 
with an overall mean FEV1 value of 46.3% predicted (Schroff et al., 2017). Dodd and 
colleagues (2011) had 297 data sets with a mean age of 69.2 years, 62.7% male and a mean 
FEV1 value of 50.9% predicted (Dodd et al., 2011). In another randomised controlled trial, 
conducted by Eaton et al. (2009), the authors had 97 COPD patients recruited from the 
greater Auckland region, New Zealand, with a mean age of 70 years, 44% male and a mean 
FEV1 of 36% predicted (Eaton et al., 2009).  
The literature discussed above appears to suggest that the home-based pulmonary 
rehabilitation was potentially capturing the right age group but in the centre-based pulmonary 
rehabilitation, with a mean age of over 74 years appeared to be older than expected. Possible 
explanations for this finding include: there is a minor flaw in the control data set where in the 
pre database era (2009-2013), the patients’ details were recorded on an Excel spreadsheet and 
91 
 
only the patient’s date of birth was recorded, or the actual age when the patient attended the 
pulmonary rehabilitation was unable to be traced. To get an estimated age value and be 
consistent with the home-based pulmonary rehabilitation intervention group participants, both 
patient samples in this study had their age measured to November 2015. However, in a recent 
Canterbury pulmonary rehabilitation outcome measure report (CCN, 2016), of the total 214 
participants, the report had suggested a mean age of 72.3 years which concurred to the thesis 
finding centre based pulmonary rehabilitation group. This appeared to be in supportive of the 
living better and older statement mentioned previously. Moreover, in New Zealand, many 
people stop working around the age of 65, because this is the age set for the New Zealanders 
to be qualified to receive the age-related Government-funded pension (New Zealand 
Government, 2016). Because the centre-based pulmonary rehabilitation has a greater 
commitment for the participants, a structured twice a week, two hours per session 
programme, the data appeared to be suggesting the centre-based pulmonary rehabilitation was 
better attended by people who were well into their retirement. In contrast, from my 
observation in my role as a pulmonary rehabilitation clinician carrying out the assessments, 
participants in the home-based pulmonary rehabilitation, may still have been working part-
time or even full-time and may therefore  not fully committed to a centre based rehabilitation 
programme. Other reasons, mentioned previously, which may prevent a patient participating 
in a pulmonary rehabilitation, include social stigma, being breathless in public, convenience, 
and transportation issues. 
The third interesting finding in the demographic profile was that the New Zealand Māori 
participants appeared to be almost four times more likely to attend a home-based programme 
than a centre-based programme. In the home-based pulmonary rehabilitation group 14% of 
the participants identified themselves as New Zealand Māori, whereas in the centre-based 
pulmonary rehabilitation, only 4% did, which is an even more startling statistic when one 
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takes into consideration the national Māori population proportion at the latest 2013 New 
Zealand Census (2013) was 15% in total and about 8% in Canterbury (New Zealand Census, 
2013). The census values suggest that the pulmonary rehabilitation service in Canterbury 
should have about 8% of Māori participants in the programme. In fact, the Home-based 
Programme attracted almost double the anticipated number (and just under the national 
percentage) and the Centre-based Pulmonary Rehabilitation Programme attracted only half 
the Canterbury percentage. Gracey and King (2009) estimate there are almost 400 million 
indigenous people in the world and a significant number of them live with in poor health 
standards. Regardless of the developmental status of the countries these indigenous people 
are native to, these peoples, whether they are living in Australia, New Zealand, United States 
of America or the United States-associated Micronesia, have higher rates of illness in cancer, 
cardiovascular, respiratory diseases, stroke, and diabetes (Anderson et al., 2006). The 
indigenous people around the globe are also faced with lower life expectancy at birth and 
higher infant mortality rates (Bramley et al., 2005). In New Zealand, Māori people living 
with COPD experience poorer health services and those who are living with a chronic lung 
condition, have longer and more frequent hospitalisations and more death associated with 
COPD when compared to the non-Māori community (Telfar et al., 2015). All the evidence 
indicates the importance of a more New Zealand Māori inclusive approach to health services.  
In a recently published paper by Levack et al. (2016), the authors stated that, regardless of 
ethnicity, the common reasons for non-attendance at a pulmonary rehabilitation programme 
was the participant’s previous experience in exercise or the health care system, the attitude 
and expectation of the people involved in the service, access issues, and the initial 
programme experience. These findings were consistent with the Ramage et al. (2016) 
findings where 75 people were surveyed, who were referred, but did not attend, a pulmonary 
rehabilitation session. Levack et al.’s 2016 explored further on these issues and revealed that 
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for the New Zealand Māori, whakawhanaungatanga (the making of culturally meaningful 
connections with others) was an important factor in determining the likelihood of a New 
Zealand Māori participant attending a programme or not. The culturally meaningful 
connections refer to practices, communication and relationship-building that are culturally 
sensitive or appropriate (Levack et al., 2016). For some Māori participants, they felt the 
absence of a holistic service would make them feel culturally unsafe, which would lead to 
lower attendance at the pulmonary rehabilitation programmes (Levack et al., 2016). This 
analysis suggests that the home-based pulmonary rehabilitation approach is a more culturally 
safe method, reduces equity differences, and is helpful for Māori, who live with chronic 
respiratory illnesses. 
The last interesting demographic finding was in the participants’ baseline severity of airflow 
obstruction shown in their spirometry results. The data showed that most of the participant 
values (close to 80% in both groups) were recorded between the moderate to severe 
categories of airflow obstruction; however, in the home-based pulmonary rehabilitation 
group, there is a sharp and obvious peak in the severe category. The home-based pulmonary 
rehabilitation group has more than 50% of the participants in the severe airflow obstruction 
category compared to 40% in the centre-based pulmonary rehabilitation programmes. The 
percentage of the predicted forced expiratory volume during the first second (FEV1), or 
known as the volume of air forced out in one second, was used to determine the severity of 
airflow obstruction in people living with COPD. The Global Initiative for Chronic 
Obstruction Lung Disease stated that the different severities are determined as follows: mild 
obstruction means the FEV1 is greater or equal to 80% of the predicted value; moderate 
obstruction means the FEV1 is less than 80% but greater or equal to 50% of the predicted 
value; severe airflow obstruction refers to an FEV1 value less than 50% but greater or equal 
to 30% of the predicted volume; and very severe airflow obstruction refers to a FEV1 volume 
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of less than 30% predicted (GOLD, 2015). Assuming that airflow obstruction is positively 
correlated to exercise capacity and functions in the researched Canterbury population, the 
home-based pulmonary rehabilitation was able to support more people living with severe 
COPD than the centre-based pulmonary rehabilitation. It can also mean that more people 
living with severely obstructed airway felt more comfortable to accept a pulmonary 
rehabilitation offer when they were assessed and treated at home. This interesting 
phenomenon may be explained by a simple example. In a typical pulmonary rehabilitation 
participant with severe airflow obstruction, the person would experience significant 
symptoms of breathlessness and fatigue, and as a result, a loss of function. In general, 
personal services, such as personal care for showering or bathing, domestic assistance for 
cleaning tasks inside the home, meals on wheels, would be put in place to support the 
person’s living. Unfortunately, the Canterbury pulmonary rehabilitation service has only one 
time frame to run the programmes, which between the hours of 12:30 and 15:30, either on a 
Monday and Wednesday, or a Tuesday and Thursday combination. This means that the 
pulmonary rehabilitation service may be unable to provide enough flexibility to fit into the 
participant’s living routine. Ramage et al. (2016) supported this viewpoint that the traditional 
pulmonary rehabilitation programme lacked flexibility from their study done on the reasons 
for non-attendance at the pulmonary rehabilitation service in Canterbury. The most frequently 
reported reason was disruption of usual routine (27.3%), followed by travel (18.2%), and 
fears or concerns about the programme (18.2%). For the home-based pulmonary 
rehabilitation, the timing was a lot more flexible when compared to the centre-based 
pulmonary rehabilitation. The participant was able to choose a one hour appointment session 
between the hours of 09:30 to 16:00 Monday to Friday. By having a home visit at a time that 
was convenient for the participant and they were comfortable with, removed the 
transportation barrier and reduced the level of anxiety and fear for participants with more 
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symptomatic breathing. This may be the reason why the more severely obstructed COPD 
participants were in the home-based pulmonary rehabilitation group: unable to attend the 
centre-based pulmonary rehabilitation due to not wanting to disrupt daily routines or concerns 
about personal safety outside the home due to breathing difficulties,.  
Primary Outcomes 
 
The CRQ was the primary outcome measure used to assess the difference between the home-
based pulmonary rehabilitation and centre-based pulmonary rehabilitation groups. The CRQ 
measures four major components of a person living with a chronic respiratory condition: 
dyspnoea, emotional function, mastery, and fatigue. Each domain is discussed in more detail 
in the following paragraphs. 
The study has shown the home-based pulmonary rehabilitation’s performance in improving 
the participant’s level of dyspnoea was not statistically significantly different from the centre-
based pulmonary rehabilitation. Both groups were able to assist the participant to achieve 
clinically significant improvement in the dyspnoea component by the end of the eight-week 
programme. The mean baseline value for the home-based pulmonary rehabilitation in 
dyspnoea was 14.2 and it improved to 18.3. Dyspnoea more commonly known as 
breathlessness is most commonly caused by exercise (exertion)-induced oxygen desaturation. 
Jenkins and Cecins reported that in 47% of referred pulmonary rehabilitation participants 
their oxygen saturation would decrease to below 90% while doing an exercise capacity 
testing (2011). The normal range for a healthy person is 95% to 99% in normal air conditions. 
The sensation of breathlessness can cause discomfort and most important of all fear and 
anxiety. Ramage et al. (2016) reported one of the reasons for people not attending pulmonary 
rehabilitation was due to fear and anxiety. One of the interviewed participants mentioned 
“That’s the thing that’s really worrying me. I don’t want to go there and do all these things, 
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and then the next couple of days be like, I can’t breathe or I’m too worn out to do anything 
you know”(Participant 59).  
The promising improvement made in the CRQ dyspnoea domain was consistent with 
previous research. Hernandez et al. (2000) found in their 60-patient RCT for people living 
with COPD that a simple home-based programme was able to achieve improvement in post-
effort and basal dyspnoea. Ghanem et al. (2010) found that at the end of their two-month long 
home-based pulmonary rehabilitation study participants were able to achieve statistically and 
clinically significant improvement in the CRQ dyspnoea domain when compared to the 
control (usual medical therapy) group (2010). A study, in Germany, which examined a home-
based exercise training for people living with moderate COPD also found a positive effect on 
the participants’ breathing status. du Moulin et al. (2008) reported a clinically and statistically 
significant improvement in the participants’ CRQ dyspnoea domain with the home exercise 
option in their 20-participant RCT. 
The current study also identified that the performance of the home-based pulmonary 
rehabilitation in supporting the emotional aspect of people living with COPD was not 
significantly different from the centre-based pulmonary rehabilitation option. As stated 
previously in the literature review, it is well known that people living with a chronic medical 
illness would have higher depressive and anxiety levels (Lou et al., 2012; Nowak et al., 
2014). The current study had shown participants involved in the home-based pulmonary 
rehabilitation had a mean baseline value of 30.1 in the CRQ emotional function domain and 
improved to 34.3 at the end of the eight-week rehabilitation.  
The CRQ emotional function domain improvement in the home-based pulmonary 
rehabilitation was supported by research. In the study by Ghanem et al. (2010) the emotional 
function domain of the home-based participants improved from a baseline of 22.1 to 33.5 at 
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the end of the programme. The change margin was both statistically and clinically significant 
(p< 0.05). Hernandez et al. (2000) showed in their randomised home-based training 
programme trial, that the emotional aspect of the quality of life in people living with COPD 
could be improved by using a home-based programme. Their participants had a baseline 
mean value of 30.8 and, when reassessed 12 weeks later, the participants were able to achieve 
a mean value of 36.5, with a p< 0.05, both clinically and statically significant improvement 
(Hernandez et al., 2000); however du Moulin et al. (2009) suggested differently. They have 
found in their study, despite the improvements made in other CRQ domains in their 
participants, the CRQ emotional function domain did not achieve any significant 
improvement at the 3-month and 6-month measurement post intervention.  
The phenomenon can be explained by the Alexopoulos et al. (2006) study. The authors 
enrolled 69 participants with the diagnoses of major depressive disorder (also known as 
MDD) and COPD in an inpatient pulmonary rehabilitation. At the end of the study, the 
authors had found these older depressed participants were responsive to the pulmonary 
rehabilitation, showing improvement of the depressive symptoms and disability (Alexopoulos 
et al., 2006). The authors concluded that the pulmonary rehabilitation programmes not only 
offered the participants the known clinical benefits but also behaviour intervention and 
supports which led to higher satisfaction with treatment regime (Alexopoulos et al., 2006). 
All these components together were thought to be the predictors of favourable outcomes for 
major depressive disorder (Alexopoulos et al., 2006). In the home-based pulmonary 
rehabilitation, the participants were seen at home. Once assessed and an exercise programme 
was designed for the participant, there was no other mechanism set in place to increase 
participants’ social interaction other than the weekly telephone call to check on progress. In a 
centre-based pulmonary rehabilitation, the participants would need to make twice weekly 
outings to the programme venue, meet up with clinicians and interact with other participants 
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in the class. This is the type of support and interaction a participant undertaking the home-
based pulmonary rehabilitation would miss out on. 
The current study also suggested no statistically significant difference between the centre-
based pulmonary rehabilitation and home-based pulmonary rehabilitation groups in the CRQ 
mastery domain, which measured the level of control the participants felt to their breathing 
condition. Both groups had similar baseline values, centre-based pulmonary rehabilitation: 
19.1 and home-based pulmonary rehabilitation: 18.7, and clinically improved by over 3 units 
in both the centre-based pulmonary rehabilitation group to 22.2 and the home-based 
pulmonary rehabilitation group to 22.0. 
Hernandez et al. (2000) supported the performance of home-based pulmonary rehabilitation 
in improving participants’ mastery level. The participants in Hernandez et al.’s home-based 
training group were able to improve their mastery level by 2.5 units, from 19.4 to 21.9 after 
12 weeks of training; however, Moore et al. (2009) and du Moulin et al. (2009) were not able 
to demonstrate any significant improvement in the mastery domain in their studies. The small 
randomised control home-based study by Moore et al. (2009), on home exercise video 
programme for people living with COPD, showed an improvement of only 0.7 unit in the 
home based group which was neither statistically nor clinically significant. du Moulin et al. 
(2009) reported an even smaller improvement in the CRQ mastery domain of 0.3 units 3 
months after a home-based intervention was instigated. This less encouraging evidence in the 
mastery domain may be attributed to the lack of feedback by the participants and also a lack 
of co-designing a self-management plan with the participants. To gain more control of a 
chronic illness and in attempt to break the chronic element of the cycle, requires the 
participant to learn a new set of skills that they are comfortable in using and constantly 
reshaping, readjusting it to fit into their daily routine. In some of the home-based exercise or 
rehabilitation groups the literature, participants would have very limited feedback once the 
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initial contacts and an exercise programme were developed for them. This may explain why 
in some research the limited improvement is seen in the CRQ mastery domain. 
The current study identified no statistically significant difference in the CRQ fatigue domain 
between the home-based pulmonary rehabilitation and centre-based pulmonary rehabilitation 
groups. The fatigue domain describes how one’s activity or energy level was affected due to 
the breathing condition; however, the study revealed that the centre-based pulmonary 
rehabilitation was able to achieve a higher and clinically significant improvement at the end 
of the programme in contrast to the home-based pulmonary rehabilitation. The home-based 
pulmonary rehabilitation was only able to achieve a mean change of 1.7 point compared to 
the 3.1 points achieved by the centre-based pulmonary rehabilitation participants. In other 
words, both the home-based pulmonary rehabilitation and centre-based pulmonary 
rehabilitation were able to achieve significant improvement in the fatigue domain, but the 
centre-based pulmonary rehabilitation was able to make a more obvious improvement. 
Hernandez et al. (2000) reported a significant improvement in CRQ fatigue domain for their 
home-based training programme for people living with COPD. A change of close to 4 points, 
from 17.4 to 21.1 for the home-based group with p< 0.05. du Moulin et al. (2009) also 
reported significant improvement in their participants going through a home-based exercise 
programme when compared to the centre based group with p<0.05. Moore et al. (2009) also 
reported significant improvement in the CRQ fatigue level in their home video exercise 
study. The clinically significant gain in the centre-based pulmonary rehabilitation group, in 
my study, can be attributed to challenges faced to ascertain or to verify that the home-based 
pulmonary rehabilitation participants had been doing the exercises effectively. Compared to 
the centre-based pulmonary rehabilitation, the home-based pulmonary rehabilitation 
participants had to take up more ownership in adapting the exercise regime to their normal 
daily life without much direct supervision from the clinician. The effect of the exercise 
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carried out by the home-based pulmonary rehabilitation would be difficult to measure. Moore 
et al. (2009) also discussed the lack of direct supervision and noted that this may lead to a 
reduction in the effect of the exercise. The variable interpretation of the Borg scale 
(intensity), weight selection for resistance type of exercises, exercise frequency, and the lack 
of formal progression to the intensity of the exercises were all commented on as the possible 
factors that could have been more closely monitored (Moore et al., 2009). It is also possible 
that people making the effort to attend a centre-based pulmonary rehabilitation are, in 
general, more motivated, or have a greater ability to create change. The effort used in getting 
to the different sessions at the centre-based pulmonary rehabilitation could also mean an 
increase in the activity level for the participant.  
Overall, the primary outcome measure, CRQ, provided useful input into the performance 
evaluation of the home-based pulmonary rehabilitation. The home-based pulmonary 
rehabilitation performed equally impressively in all domains of the CRQ when compared to 
the centre-based pulmonary rehabilitation. The only advantage the centre-based pulmonary 




Four secondary outcome measures were used in this thesis project. They were the Hospital 
Anxiety and Depression Scale (HADS), the COPD Assessment Tool score (CATS), one-
minute sit-to-stand test (1MSTST) and the EuroQol five dimension questionnaire (EQ-5D). 
The HADS and CATS measurements revealed no significant difference between the home-
based pulmonary rehabilitation and centre-based pulmonary rehabilitation groups. In other 
words, home-based pulmonary rehabilitation was performing as effectively as the centre-
based pulmonary rehabilitation in supporting people living with COPD and mental health 
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issues, on the basis of the HADS results. The CATS measurements indicated the home-based 
pulmonary rehabilitation participants were able to learn new knowledge equally as well as the 
centre-based pulmonary rehabilitation group and also able to implement changes and 
improvements into their normal activities of daily living, leading to better self-management 
skills. 
Unfortunately the same could not be said for the 1MSTST and EQ-5D between the two 
groups. In the current study, despite both home-based pulmonary rehabilitation and centre-
based pulmonary rehabilitation groups having changes in the participant’s exercise capacity, 
the improvement in the centre-based pulmonary rehabilitation was much more obvious. In the 
home-based pulmonary rehabilitation group, there was no change (-0.2 repetition) in the 
1MSTST value before and after attending the programme as compared to a mean change of 
2.5 in the centre-based pulmonary rehabilitation group before and after the programme, 
which is a difference of 2.8 repetitions between the two groups. The plausible reason to 
explain this observation could be due to the small sample size of the home-based pulmonary 
rehabilitation group (20), the lack of exercise supervision in the home-based pulmonary 
rehabilitation (as previously mentioned in the CRQ fatigue section) and the potential 
selection bias of the home-based pulmonary rehabilitation participants. It is important to note 
that the concept of home-based pulmonary rehabilitation was first thought of due to a 
significant number of referred participants not able to attend or complete a pulmonary 
rehabilitation programme due to various reason. As was outlined in the demographic profile 
section of this chapter although the home-based pulmonary rehabilitation participants were 
younger a larger proportion of them were in the severe category of COPD. This group of 
participants were in general less committed, did not seem to understand the benefits of 
rehabilitation, and (probably due to the severity of their COPD) they are living with more 
breathlessness. On top of the above selection bias reasons, another important factor would be 
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the lack of direct supervision to support, encourage, and progress participant’s exercise 
status. All these factors, would lead to a less favourable results in the exercise tolerance 
related outcome measures (i.e. CRQ fatigue domain and 1MSTST). 
In the EQ-5D outcome measure, the home-based pulmonary rehabilitation group appeared to 
be no worse than the centre-based pulmonary rehabilitation group in helping the participants 
to move towards a more positive experience in their quality of life. However, looking purely 
at the numbers, the centre-based pulmonary rehabilitation appeared to be able to provide 
bigger and more significant changes to the lives of the participants. Due to the lack of 
complete data sets in the control centre-based pulmonary rehabilitation group from the 
historical database, this study had referred to a reference range tested and provided by 
Pickard et al. (2008) and the minimal clinical important difference suggested by Zanini et al. 
(2015) to analyse the data in hand. It is interesting to see, that on the basis of the EQ-5D 
indices, the home-based pulmonary rehabilitation had a lower perception of quality of life at 
the beginning of the programme (0.59) when compared to the centre-based pulmonary 
rehabilitation group (0.62) and reference range (0.60-0.78) provided by Pickard et al. (2008). 
Once again, this result is not unexpected because of the selection bias mentioned previously 
that more home-based pulmonary rehabilitation participants were living with more severe 
COPD. The pulmonary rehabilitation programmes were able to improve the values and 
elevated both groups’ EQ-5D indices to within the expected reference range, but still below 
the mean reference value (0.69).  
In the EQ-5D VAS domain, despite the lower quality of life perception in the home-based 
pulmonary rehabilitation group, mentioned previously, the home-based pulmonary 
rehabilitation participants tended to feel they were at a better health state when compared to 
the centre-based pulmonary rehabilitation participants (6.67 vs. 5.85). At the end of the 
programmes, both groups were able to make positive improvement to the visual analogue 
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scale; however, both groups were not able to reach the recommended minimal clinical 
important difference of 0.8. The home-based pulmonary rehabilitation made a 0.66 point 
change and the centre-based pulmonary rehabilitation, 0.35 change. A possible explanation to 
this interesting EQ-5D VAS finding could be due to the subjective self-rating nature of the 
questionnaire. The answers to the questionnaire would be based on the perceptions the patient 
had on the day. These perceptions can be influenced by many external factors such as activity 
level, mood, life experiences, and socialisation. Most of the participants in the home-based 
pulmonary rehabilitation group were mostly house bound or felt more comfortable staying at 
home. The lack of socialisation may lead to a distorted perception of what is good health. 
Those living with COPD and who had remained active in their community quite often 
reported to the pulmonary rehabilitation service team that that they felt embarrassed coughing 
or becoming breathless with minimum exertion in front of their family and friends. These 
active people living with COPD would get regular feedback and comments from people 
without breathing conditions saying their breathing is “a bit off” or asking them “do you need 
help”. These comments actually made these active people very conscious of their breathing 
condition constantly. In contrast the more house-bound home-based pulmonary rehabilitation 
participants may develop a false sense of good health because of a lack of (or reduced 
exercise challenges) at home and a lack of feedback from people without a breathing 
condition. Another common phenomenon when visiting these home-based pulmonary 
rehabilitation participants is they would avoid making themselves become breathless. A 
common sight would be upon arrival of the home visit, the individual would be sitting in a 
comfortable Lazyboy couch with the leg rest up, watching television. When interviewed on 
their breathlessness status during the day, quite often these participants would respond saying 
their breathings were “fine” or “good”. But with further questioning the participants would 
share how difficult it was to walk from the living room to the bedroom and how making a cup 
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of tea standing up in the kitchen would make them breathless. Their solution to the problems 
these activities of daily living created was to rely on the support provided by the spouse, 
family members, or social services. In other words, during the day, the individual would be 
supported and helped by external sources so the chance of having to exert him or herself 
would be minimal. These participants’ reports of breathing as being “fine” or “good” was not 
a false statement but merely the result of a strategy that had been developed over the years to 
reduce the unpleasant experience of breathlessness. Just like any fitness training regime, 
however, those living with breathing conditions should challenge their breathlessness status 
every day with exercises to improve their overall quality of life. 
Spirometry 
It is worth noting in the study, the home-based pulmonary rehabilitation group had 5% of the 
participants without a spirometry result. The larger than expected percentage could be due to 
the small sample size (n=21) of the group but this value could also be uncovering another 
serious issue, regarding access to a standardised spirometry test for people in the community. 
Chronic obstructive pulmonary disease is demonstrated by a non-reversible airflow 
obstruction in spirometry, hence the access to spirometry testing is essential to a diagnosis of 
COPD (GOLD, 2013). Prior to 2007, standardised spirometry was carried out only at one 
central venue, the Christchurch Hospital Respiratory Physiology Laboratory. It is paramount 
to have a certified and standardised spirometry testing process in place because misdiagnosis 
of COPD can be as much as 27% (Jones et al., 2008). At the central venue, there were close 
to 8,000 referrals a year and only about 850 of these referrals were from the primary health 
care setting (Epton et al., 2015). As suggested in the introductory chapter, the estimated 
COPD population in the Canterbury region should be between just over 16,000 to close to 
77,000 people. In other words, 8,000 referrals a year is only the tip of the ice berg. It is 
unrealistic to expect the hospital service to continue to perform all the spirometry testing 
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because most people in the Canterbury region do not live centrally and the demand for 
spirometry will only continue to rise (Epton et al., 2015). In 2008, a team of clinicians and 
scientists developed a quality assurance and education framework and a virtual interface 
software so that more people, especially from general practices, can be trained to deliver 
standardised spirometry. This had led to an extra 5,409 high quality spirometry tests being 
delivered in the community between the years 2009 and 2013 (Epton et al., 2015). It is hoped 
that with this free service now readily available at 10 geographically chosen approved 
providers more people living with a breathing condition would have easier access to find out 
what their lung function is like. It is also worth keeping in mind that, regardless of the ease of 
access to a service, if someone in the community does not have the finance and means to 
access a form of transportation, does not feel comfortable or supported to attend to such a 
service, or does not feel there would be any health benefits in having a spirometry test, then 
they will still not have it done. It is, therefore, important for the service as a whole, if at all 
possible, to put in place the non-medical support first so that individuals would have a greater 
chance of participating in the required medical intervention. 
Home-based pulmonary rehabilitation and centre-based pulmonary rehabilitation processes 
The length of the home-based pulmonary rehabilitation, eight weeks, was set in reference to 
the centre-based pulmonary rehabilitation programmes. As mentioned in the introductory 
chapter, Spruit et al. (2013), in their analysis were unable to identify and justify what would 
be the optimal number of sessions per week and staff-to-patient ratio for each of the centre-
based pulmonary rehabilitation sessions. Participants in the centre-based pulmonary 
rehabilitation, on some occasions, were unable to commit to the whole of the programme, 
designed to deliver two sessions a week, and every session for two hours. Programmes that 
are designed to support behavioural and physical changes should happen as often as possible 
and for as long as possible; however this approach is not practical nor realistic. The most 
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common explanation as to the inability to attend the programme related to the structure or 
format of the programme, the number of days required per week, the time the programmes 
were run, or the amount of time spent per session (Ramage et al., 2016). The recommended 
number of exercising sessions per week required for health purposes ranges from three to five 
sessions and each session should last for 20-30 minutes. For centre-based pulmonary 
rehabilitation, it was thought two sessions a week would be sufficient because the service 
would expect the participant to carry out at least one exercise session on their own at home 
when they are attending a pulmonary rehabilitation programme. This would make up the 
number of sessions to the minimum requirement of three exercise sessions per week. For the 
home-based pulmonary rehabilitation, the approach was different. Home based pulmonary 
rehabilitation provided once a week telephone call support in hope that the participants would 
follow through the exercise regime developed at the initial assessment session. This, as 
mentioned previously in this chapter, is one of the limitations of the home-based pulmonary 
rehabilitation programme, the inability to verify if the exercises actually happened. Changes, 
however, in technology may be able to solve this problem, such as the use of activity tracking 
device like a FitBit will be able to provide this data. 
The conceptualisation of the home-based pulmonary rehabilitation was based on the 
significant number of pulmonary rehabilitation referrals that were not able to translate into 
the completion of a pulmonary rehabilitation programme. The venues chosen for the centre-
based pulmonary rehabilitation were based on Christchurch Hospital Respiratory Service data 
on COPD related discharges. The University of Canterbury Geography Department was then 
able to report on the hot spot areas of residence for patients with COPD related discharges. 
This was very useful information to have when looking for the right pulmonary rehabilitation 
venues in the community. No venue will ever be perfect for everyone, but by using the data 
to determine optimal sites venues will be more accessible and more convenient to the 
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potential participants’ homes. Furthermore, the reasons for non-attendance of the centre-
based pulmonary rehabilitation are so wide and complex, it is not an issue that can simply be 
solved by placing a pulmonary rehabilitation venue right next to patients’ homes so they will 
attend the programme. The pulmonary rehabilitation service recognised that when dealing 
with a group of people, who live with a chronic condition, things would always be more 
complex than it first appeared. First, they need to manage the fluctuation of symptoms caused 
by the chronic condition on a daily basis, whether it is a physical or emotional challenge. In 
addition, this group of people also need to deal with family, work, finance, and all other 
aspects of a normal life. All these can greatly influence the motivation for a patient to attend a 
centre-based pulmonary rehabilitation. This was the exact reason that home-based pulmonary 
rehabilitation would be an ideal solution, offering the people of Canterbury a different model 
for pulmonary rehabilitation. In cases where the centre-based pulmonary rehabilitation did 
not work for the individual the pulmonary rehabilitation service now has another equally 
effective option, the home-based pulmonary rehabilitation.  
Lastly, it may seem as if not much effort was put in place to follow up on the two home-
based pulmonary rehabilitation participants who were not able to have post-programme 
assessments. The pulmonary rehabilitation service believes strongly in the informed consent 
process and also the service is looking after a population group that had a vast amount of 
experience in life and caring for themselves. Ideally, any post-programme data should be 
collected within two weeks after the completion of the programme. This is to prevent any 
deconditioning (if the participant choses to stop exercising after the programme) or skewing 
(if the participant continues to exercise and therefore improves his fitness level) of the data. 
When making the post-assessment appointments, the participants were informed of the 
reasons and content of the home visit and they have the right to agree or disagree with the 
appointment. If they disagreed, an explanation would be given on the benefits of having a 
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post assessment and alternate appointment times would also be offered. Even so, two home-
based pulmonary rehabilitation participants decided not to have post-assessment conducted. 
Study limitations 
 
Recruitment limitations: One important limitation of this study would be the pool of research 
participants. The pulmonary rehabilitation governance group agreed to test the concept of the 
home-based pulmonary rehabilitation on the group of participants who were not able to 
complete a centre-based pulmonary rehabilitation or whom the service had failed to establish 
formal contacts with through the standard centre-based pulmonary rehabilitation processes. In 
other words, the research participants were likely to be coming from a less motivated, less 
engaged with health services position, and may be living with more severe symptoms of 
respiratory conditions. These second chance participants may not represent the true general 
pulmonary rehabilitation participants in the Canterbury region. But, this group of people may 
also be the most suitable group to test this new home-based pulmonary rehabilitation service 
on, the very people the service is trying to reach out to. There are a couple of reasons for this. 
They already knew about the pulmonary rehabilitation service, and had some understanding 
of the process and the purposes of pulmonary rehabilitation. Second, the majority of 
participants, who failed to fully engage in the pulmonary rehabilitation services, had genuine 
health or commitment reasons. By removing the commitment and transportation barriers, 
these participants in need may once again establish contacts with the health services and 
improve their health by participating in the home-based pulmonary rehabilitation.  
The small home-based pulmonary rehabilitation sample size (n= 21) may exaggerate the 
effects of the home-based programme. This limitation was mainly due to the limited resource 
available, the physician time for patient assessment, and only one physiotherapist (myself) 
was available to monitor and follow up on all participants. 
109 
 
Time frame limitations: The assessment time frames were fixed and rigid in this research 
study to ensure results data could be produced within a tight time frame. This meant some 
potential participants were left out of the study. These potential participants were excluded 
from the programme when they were unable to complete the initial home visit assessment 
either due to not being at home at the agreed time or because they called to cancel the home 
visit appointment without rebooking. Similarly at the end programme assessment, every 
effort was made to re-assess the home-based pulmonary rehabilitation participants within a 
two-week period. If the participants were unavailable to be reassessed in the two-week 
window due to another commitment, sickness or death, they were excluded from the study. 
The rigid assessment structure is to be regretted, but with very limited staff and time 
resources, this was the only possible approach to keep the home-based pulmonary 
rehabilitation project moving forward. 
Data limitation: The incomplete data sets from the historical spreadsheet hindered a more 
complete quality of life (EQ-5D) comparison analyses between the home-based pulmonary 
rehabilitation and centre-based pulmonary rehabilitation. The data storage issue was only 
identified in recent years. In 2013, the pulmonary rehabilitation service decided to migrate as 
much data as possible to the new MedTech system, but then they realised it would be too 
resource intensive to migrate all the data from 2009 to 2013 to the new database. The service, 
therefore, decided to set a specific time to stop using the old storage format and to begin 
storing data into the new system. The old storage format was saved in Excel spreadsheets and 
it was very difficult to access because the data were stored under multiple file names and in 
poorly organised folders. This problem only became obvious when I began interrogating the 
routinely collected data for research purposes much was lost or not recorded in a useful 




The Hawthorne effect: This is the effect of knowing you are being studied. Mayo (1933) 
described this effect as the behavioural changes made by the participants as a result of 
knowing that they were being studied or monitored. This may motivate the participants to 
make some positive changes, unrelated to the study, to their lifestyles because they wanted to 
be helpful to the study. From the consent form, the 21 home-based pulmonary rehabilitation 
participants understood they were part of a pilot study, the result would be reported to the 
governance group and potentially changing the health practice. This alone, may positively 
change the attitudes of the participants and produce favourable results. 
Summary of key findings 
The key findings of this study are outlined according to the order in which they were 
discussed in this chapter. Each of the key findings will be described in a concise and 
abbreviated manner. More information on each of the key findings can be found within this 
chapter as required. 
 The home-based pulmonary rehabilitation was able to show a better gender 
distribution (almost at half of each gender) when compared to the centre-based 
pulmonary rehabilitation (one third males vs. two third females). This finding can be 
explained by the men’s avoidance in health utilisation. But the avoidance barrier 
appeared to have been removed when the health service was delivered in the home. 
 The home-based pulmonary rehabilitation model was able to capture people who are 
younger, with a mean age of 68.76 years compared to 74.61 years in the centre-based 
pulmonary rehabilitation. This finding may relate to the fact that people are working 
longer and reflect an older and healthier Canterbury population. People who could 
attend a centre-based pulmonary rehabilitation were most likely to be retirees which 
would explain the older mean age. 
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 The home-based pulmonary rehabilitation was able to have higher Māori 
representation when compared to the centre-based pulmonary rehabilitation. The 
home-based pulmonary rehabilitation had 14% of the participants who identified as 
Māori compared to 4% in the centre-based pulmonary rehabilitation. It is important to 
identify suitable approaches to care for the indigenous people of the land. The home-
based pulmonary rehabilitation model seemed to be a more acceptable mode of 
delivery to the Māori community. 
  The data seemed to suggest that in the home-based pulmonary rehabilitation there 
was a higher proportion of the members (50%) who had severely obstructed airway 
disease compared to 40% in the centre-based pulmonary rehabilitation group. People 
living with more severe airway disease may prefer to be assessed and seen at home. 
This group of people may be more symptomatic from their breathing conditions and 
as a result more reluctant to leave the house. 
 The home-based pulmonary rehabilitation was able to improve the participants’ 
perception of their breathlessness as much as the participants in the centre-based 
pulmonary rehabilitation. 
 The home-based pulmonary rehabilitation performed as well as the centre-based 
pulmonary rehabilitation in managing participant’s emotional functions. 
 There is no statistically significant difference between the home-based pulmonary 
rehabilitation and centre-based pulmonary rehabilitation in how the participants felt 
they are in control of their breathlessness. 
 There is no significant difference between the home-based pulmonary rehabilitation 
and centre-based pulmonary rehabilitation in supporting participants to improve their 
fatigue status; however, the centre-based pulmonary rehabilitation group was able to 
achieve a significantly higher improvement when compared to the home-based 
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pulmonary rehabilitation group. This finding can be explained by the lack of 
supervised exercise sessions in the home-based pulmonary rehabilitation group and 
possibly the increase in the activity level by merely making an effort to attend a 
centre-based pulmonary rehabilitation. 
 The HADS questionnaire revealed that the home-based pulmonary rehabilitation and 
centre-based pulmonary rehabilitation produced similar outcomes in the management 
of anxiety and depression. 
 The CATS questionnaire suggested that both home-based pulmonary rehabilitation 
and centre-based pulmonary rehabilitation were able to provide the participants 
similar skills in managing their own breathing conditions. 
 In the 1MSTST measure, both home-based pulmonary rehabilitation and centre-based 
pulmonary rehabilitation showed the ability to improve participant’s ability to 
perform the test; however, the centre-based pulmonary rehabilitation was able to 
produce a greater improvement when compared to the home-based pulmonary 
rehabilitation group. 
 In the EQ-5D questionnaire, both the home-based pulmonary rehabilitation and 
centre-based pulmonary rehabilitation groups were able to improve participant’s 
quality of life. But once again, the centre-based pulmonary rehabilitation was able to 
produce a stronger result at the end of the programme. 
 A larger than expected proportion of the participants in the home-based pulmonary 
rehabilitation did not have a spirometry result. This could be due to the lack of access 
to spirometry testing or a lack of non-medical support to the participants, such as 
transport, to access spirometry. 
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Health implications and recommendations for clinical practice 
A number of key health implications and recommendations to the service were generated 
from the key findings. The recommendations are listed according to the order which they 
were discussed in this chapter. These points are also written in an abbreviated manner. More 
information on each point can be found in the discussion chapter or in the literature review of 
this thesis. The intent of the following recommendations is to assist and encourage clinicians 
working in the centre-based pulmonary rehabilitation setting to consider home-based 
pulmonary rehabilitation as a clinically acceptable intervention to people who were not able 
to complete a centre-based pulmonary rehabilitation. 
 Home-based pulmonary rehabilitation should be considered to be clinically as 
effective as the centre-based pulmonary rehabilitation when dealing with people or 
communities with increased needs. The thesis project has shown the positive effects 
of the home-based pulmonary rehabilitation which were as effective as the centre-
based pulmonary rehabilitation.  
 The centre-based pulmonary rehabilitation providers should analyse the demographic 
and outcome measures data on a regular basis so that the pulmonary rehabilitation 
service can continue to evolve according to the needs of the users. For example, 
home-based pulmonary rehabilitation would be an ideal rehabilitation option if the 
service would could offer this intervention to Māori males, who are in their 60s and 
who have severe airway obstruction disease. 
 The patient’s own home would be the best place for learning new knowledge and a 
comfortable environment to start modifying their lifestyle for the better. At the home 
setting, the clinician and patient power imbalance is minimised. The home-based 
pulmonary rehabilitation provides exactly this service to people living with chronic 
respiratory condition in the community. 
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 In situations where people living with chronic respiratory illness could not attend 
centre-based pulmonary rehabilitation, but would benefit from rehabilitation, they 
should be offered alternative options. The alternative options could vary from a one-
off home visit with a physiotherapist or a nurse to go over self-management strategies 
to modified forms of pulmonary rehabilitation for example the home-based 
pulmonary rehabilitation or after-hours information sessions. 
 When delivering a home-based pulmonary rehabilitation, more effort and time should 
be spent on the supervision and progression of the home-based exercises. The weekly 
follow-up with the patient should include specific instructions on making sure the set 
exercise intensity at the first home visit is still effective and continue to motivate the 
participants to challenge his or her comfort zone. This is aimed to maximise the 
effect of fatigue management and fitness training through exercise. 
At time of writing  
 In December 2016, the Pulmonary Rehabilitation Working Group, the governance 
group to the Canterbury Pulmonary Rehabilitation Service, completed its review of 
the report generated from this thesis project and gave its mandate to start home-based 
pulmonary rehabilitation service in the Canterbury region, beyond a pilot study. 
 To the best of our understanding, this would be the first structured home-based 
pulmonary rehabilitation service in New Zealand. 
 A one page flowchart was produced to assist clinicians to better understand the home-
based pulmonary rehabilitation (Appendix N). 
 A one page long patient information flyer was generated. This flyer will go out 
together with the appointment letter in the post once the service has established 
contact with the home-based pulmonary rehabilitation participant. 
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 A new strategy, using pedometers was put in place, as a result of the review, to better 
monitor the exercise progress of the home-based pulmonary rehabilitation. This was 
put in place with the hope that with more visual and motivating feedback there would 
be an improvement in the final level of fitness. 
 An extra education component was added to the weekly contact. Each week, there 
will be a specific discussion topic to go through with each participant. This was put in 
place to encourage the home-based pulmonary rehabilitation participants to engage 
with the valuable information resources given to them on the initial visit. With a 
better understanding of their own condition there can be better self-management 
skills. 
 The first home-based pulmonary rehabilitation patient Mrs A was seen on the 4th April 2017 
under the new and PRWG mandated framework. Currently, there are 23 active referrals on 
the home-based pulmonary rehabilitation list. 
 The Canterbury Pulmonary Rehabilitation Service has successfully recruited an exercise 
trainer (at 0.6 full-time equivalent) to work together with the physiotherapist in charge of the 
home-based programme, to ensure adequate support to the patients and smooth running of the 
programme. 
 In addition to the above, it has come to my attention of a just-published article with 
very similar process to this thesis project. Holland et al. (2017) also noticed the poor 
uptake in the centre based pulmonary rehabilitation programmes in Australia. 
Therefore, the authors decided to undertake a randomised controlled trial with 12-
month follow up to examine the effect of the home based pulmonary rehabilitation 
programme in comparison to the centre based pulmonary rehabilitation over a two and 
half year period (October 2011 to April 2014). The authors recruited 166 participants 
from two tertiary based hospitals in Melbourne. The participants were then randomly 
assigned to either the home based or the centre based programme. Eighty-six 
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participants were allocated to the centre based rehabilitation programme and 80 were 
enrolled to the home based rehabilitation programme. The centre based programme, 
was the standard eight-week long programme, whereas the home based programme, 
the participants would receive a home visit follow by seven weekly phone contacts 
from a physiotherapist. Holland et al. (2017) had found that in their primary outcome 
measure, the analysis has confirmed non-inferiority of the home based programme in 
the six-minute walking test and in the secondary outcome measure, the chronic 
respiratory questionnaire, at the end-programme phase. Holland and colleagues 
(2017) also reported in their 12-month follow up, neither model was able to maintain 
effectively the improvement made at the end of the programmes. The authors 
concluded by recommending that home based pulmonary rehabilitation should be 
considered when centre based programme is not accessible by the participant. This 
recommendation concurs with the finding of this thesis project. 
 
Recommendations for future research 
 
 Future research should incorporate a follow-up period at 6-months and 12-months to 
examine the long-term effects of the home-based pulmonary rehabilitation. The 
immediate effects after completing a home-based pulmonary rehabilitation appeared 
to be no worse than the centre-based pulmonary rehabilitation. It would be useful to 
find out how long the carry-over effect lasts after completing a home-based 
pulmonary rehabilitation programme. 
 The next home-based pulmonary rehabilitation study should recruit more participants 
to the intervention group. The current thesis study had 21 participants in the 
intervention group. A small sample size group means a small change in the group 
profile or outcome measure could easily exaggerate the final results. 
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 Further research could also look into the actual health cost benefit and the effect of 
the home-based pulmonary rehabilitation. Currently, the PRWG has been running an 
annual analysis on the number of respiratory related hospital admissions against those 
people who 1) were referred to the centre-based pulmonary rehabilitation; 2) attended 
less than eight centre-based pulmonary rehabilitation sessions (less than half of the 
programme); and 3) completed a centre-based pulmonary rehabilitation (attended 
more than eight pulmonary rehabilitation sessions). A similar analysis could also be 
done for the home-based pulmonary rehabilitation. 
 A systemic review could also be conducted to find out what exercise equipment 
would be most beneficial to a home bound person living with a breathing condition. 
The current thesis study used an exercise DVD, but we have found the home-based 
pulmonary rehabilitation participants did not improve as much in the fatigue 
management and fitness level when compared to the centre-based pulmonary 
rehabilitation participants. The PRWG had added a pedometer to the exercise regime 
to motivate the participants to be more mobile. 
 Finally, more research should look into what type of maintenance programme would 
suit these people who have completed home-based pulmonary rehabilitation. 
Currently, people who completed centre-based pulmonary rehabilitation are 
encouraged to go on to a maintenance exercise programme to maintain what they 
have gained. No such service exists for the less mobile, less motivated and home 







This study has successfully demonstrated that the home-based pulmonary rehabilitation, a 
modified delivery model to the gold standard centre-based pulmonary rehabilitation practice, 
was still effective in supporting the participants to achieve positive changes. The home-based 
pulmonary rehabilitation was better at reaching out to the younger, male, Māori and the 
severe airway obstructed participant groups. The main weaknesses identified from the study 
results were the relatively small intervention sample size and the weaker improvement 
margins in the fatigue management and 1MSTST measures; however, these minor 
weaknesses should not discourage clinicians from rolling out home-based pulmonary 
rehabilitation in their communities. Simple strategies can and have been put in place to 
strengthen the improvement margins, for example a more structured weekly telephone 
contact with specific questions targeting and motivating the participants to exercise and learn 
from the given educational resources. 
Lastly, as a New Zealand pioneer to the home-based pulmonary rehabilitation, based on the 
study results and literature review findings, there are three concluding comments to persuade 
clinicians and providers to consider implementing home-based pulmonary rehabilitation to 
their hard to reach participants living with chronic respiratory conditions. 
1. The current thesis study has demonstrated that the home-based pulmonary 
rehabilitation performed no worse than the gold standard centre-based pulmonary 
rehabilitation in all outcome measures.  
2. The current thesis study has also demonstrated that the home-based pulmonary 
rehabilitation was able to capture patient groups which were hard to reach out to in 




3. The home-based pulmonary rehabilitation is a true patient-centred health delivery 
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Appendix C: Information sheet 
 
School of Health Sciences 
University of Canterbury 
Private Bag 4800 
Christchurch 8140 
 
Tel: +64 3 366 7001  
Fax: + 64 3 364 2490 
Email: healthsciences@canterbury.ac.nz  
 
Researcher; David Chen, daveynztw@gmail.com 
 
Supervisor; Assoc. Professor Ray Kirk; School of Health Sciences, raykirk@canterbury.ac.nz  
                    
To examine the effects of DVD exercises on exercise tolerance in participants of the 
Canterbury home-based pulmonary rehabilitation programme  
 
Dear …………………, 
My name is David Chen and I am a Masters student in the School of Health Sciences, Canterbury 
University. I am conducting a research study as part of the requirements of my master’s degree and  
I am investigating the effects of two basic exercise technologies (pedometer and DVD exercises) on 
exercise tolerance in the participants of the Canterbury home-based pulmonary rehabilitation in 
Canterbury. 
The American Thoracic Society (ATS) and the European Respiratory Society (ERS) have jointly defined 
pulmonary rehabilitation as “a comprehensive intervention based on a thorough patient assessment 
followed by patient-tailored therapies that include, but are not limited to, exercise training, 
education and behaviour change, designed to improve the physical and psychological condition of 
people with chronic respiratory disease and to promote the long-term adherence to health enhancing 
behaviours” (ATS guidelines 2013). 
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The pulmonary rehabilitation is an evidence-based health intervention. It has been shown to reduce 
the risk of hospital admissions and mortality in people living with chronic obstructive pulmonary 
disease (Puhan, Scharplatz, Trooters & Steurer, 2005). The pulmonary rehabilitation programme is 
also known to demonstrate the effect of improving participants’ dyspnoea, fatigue levels and the 
sense of control over their respiratory condition (Lacasse, Maltais & Goldstein, 2004). In the 
Canterbury HealthPathways website, the respiratory physicians described pulmonary rehabilitation 
to be “at least as effective as inhaled medications” (Canterbury HealthPathways, 2014). 
The Canterbury pulmonary rehabilitation programme was established in the late 1980s in 
Christchurch. It was initially solely supported and facilitated by the Christchurch Hospital Respiratory 
Services in one central city venue. The advent of the Canterbury Initiative in 2009 and in accordance 
with the government’s health direction “Better, Sooner, More Convenient health care in the 
community” the pulmonary rehabilitation programme was able to be expanded to the wider 
Canterbury community. 
Over the last five years in the community, despite bringing the pulmonary rehabilitation venues 
closer to patients’ neighbourhood, the uptake and drop-out rates were still consistent with the 
international data, far from ideal. Only around 1% of all the chronic obstructive pulmonary disease 
(COPD) patients accessed pulmonary rehabilitation and close to 50% (44%) drop-out rate after the 
participants were referred to the pulmonary rehabilitation by their health professionals. 
Home-based pulmonary rehabilitation has surfaced in the recent years and thought to be the likely 
solution to the poor uptake and the high drop-out rates. It has been shown to be as effective as 
outpatient pulmonary rehabilitation and a reasonable alternative for managing people living with 
COPD (Mendes de Oliveira et al., 2010). 
My research question is; ‘Could the DVD exercise give forth a better exercise tolerance improvement 
in a home-based pulmonary rehabilitation’ I intend to recruit 50 participants from the “Did-not-
attend” folder of the Canterbury pulmonary rehabilitation Medtech database. I would offer the 
participants a one-off standardised education session based on the “Move on up” DVD. The 
participants will also be shown the exercises recorded in the “Move on up” DVD. I will follow the 
patients for eight weeks with weekly phone call or text messages. There will be objective and 
subjective assessments (CRQ, CAT score, 1-minute sit-to-stand, HADS and EQ-5D) pre and post 
intervention to monitor changes. 
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It is hoped that the findings of the study will give a clearer understanding of whether the DVD 
exercises can encourage improvement in exercise tolerance level and can the other assessment 
results from the Canterbury home-based pulmonary rehabilitation be comparable to the local and 
international data. 
 
In this research, you will be treated by me, David Chen, a registered physiotherapist and referred to 
other health services as indicated. Follow up contacts via phone or text message will be done by me 
as well. 
 
In the performance of the task there will be no risk to you in consenting to the intervention. 
 
You may receive a copy of the project results by contacting me at the conclusion of the project. 
 
Participation is voluntary and you have the right to withdraw at any stage without penalty. If you 
withdraw I will remove information relating to you prior to my thesis being submitted to the 
University of Canterbury. 
 
The results of the thesis may be published, but you may be assured of the complete confidentiality 
of data gathered in this investigation: your identity will not be made public without your prior 
consent. To ensure anonymity and confidentiality no identifying names will be used in the thesis. 
The data will only be accessed by myself, the community respiratory team and my supervisor. A 
completed thesis is a public document and will be available through the UC library.  
 
This project is being carried out as a requirement for my Masters in Health Sciences degree under 
the supervision of Ray Kirk who will be pleased to answer any concerns you may have about 




This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics Committee, 
University of Canterbury, Private Bag 4800, Christchurch (human-ethics@canterbury.ac.nz).  
If you agree to participate in the study, you are asked to complete the consent form. 
 
Please txt or email me at; 
daveynztw@gmail.com 









Appendix D: Consent Form  
 
School of Health Sciences  
University of Canterbury 
Private Bag 4800 
Christchurch 8140 
 
Tel: +64 3 366 7001  
Fax: + 64 3 364 2490 
Email: healthsciences@canterbury.ac.nz 
 
Researcher; David Chen daveynztw@gmail.com 
  
 
‘To examine the effects of DVD exercises on exercise tolerance in participants of the Canterbury 
home-based pulmonary rehabilitation programme’ 
 
I have been given a full explanation of this project and have had the opportunity to ask questions. 
I understand what is required of me if I agree to take part in this research. 
I understand that participation is voluntary and I may withdraw at any time without penalty. 
Withdrawal of participation will also include the withdrawal of any information I have provided 
should this remain practically achievable. 
I understand that any information or opinions I provide will be kept confidential to the researcher 
David Chen or his supervisor Ray Kirk and that published or reported results will not identify the 
participants or my place of work. I understand that a thesis is a public document and will be 
available through the UC library and the Community Respiratory Services team Office at 160 Bealey 
Avenue. 
 
I understand that all data collected for the study will be kept in locked and secure facilities and /or in 




I understand the risks involved in taking part in the study and how they will be managed if required.  
I understand that I am able to receive a report on the findings of the study by contacting the 
researcher at the conclusion of the project. 
I understand I can contact David Chen at daveynztw@gmail.com or Ray Kirk 
ray.kirk@canterbury.ac.nz  for further information. If I have any complaints, I can contact the Chair 
of the University of Canterbury Human Ethics Committee, Private Bag 4800, Christchurch (human-
ethics@canterbury.ac.nz)  
 
I would like a summary of the results with a tick box on the consent form □ 
 
By signing below I agree to participate in this research project. 
 
I, ___________________________________ (please print your full name) consent to take part in the 
above study. 
Signature ___________________________   Date _____________________ 
































































Appendix K: One-minute sit-to-stand instructions 
One-Minute Sit-to-stand Test 
A 46-48cm height armless chair was used for the STST. Participants were instructed to keep 
their legs shoulder-width apart with approximately 90 degrees knee flexion, placing hands on 
hips, laps or across the chest to eliminate upper limb assistance.  
 
A practice STS was performed to ensure safety and familiarity with the movement. The 
standard verbal instructions were  
 
“The sit-to-stand test will go for one minute. You should do as many 
repetitions as possible at a speed you are comfortable with. When 
you are standing up, you should not be using the arms for support. 
You can have short breaks as needed.”  
 
Initiation of the test began with “attention, ready, go”;  
 
participants were reminded when there was 15 seconds of the test remaining and when to 
stop.  
 
One repetition comprised full knee extension in standing followed by a controlled return to a 







Appendix L: Borg scale of exertion 
0     None 
0.5    Very, very light 
1     Very light 
2     Light 
3     Moderate 
4     A little severe 
5     Severe 
6 
7     Very Severe 
8 
9     Very, very severe 






Appendix M: Phone call protocol: 
Would you establish with the participant which phone number to use first? Would they always have a 
cell phone and land line? Land line first then cellphone 
Is it Ok with the participant to leave a message if they are unavailable? yes 
If another member of the family answers the call what would you say? Preferable to speak to the 
patient direct. 
How many attempts would you make? maximum 3! 
1. Call home number 
 Answer- offer encouragements to continue with breathing exercise and exercise regime, 
document on MedTech 
 No answer 
o  Voice box- leave a message to encourage exercise and breathing ex, document on 
Medtech 
o No voice box- try mobile phone number 
2. Call mobile phone number 
 Answer- offer encouragements to continue with breathing exercise and exercise regime, 
document on Medtech 
 No answer 
o Voice box- leave message to encourage exercise and breathing ex, document on 
Medtech 
o No voice box- document on MedTech 
Standardised conversation prompts 
 “Hello this is xxx calling from the home-based breathing exercise programme, how are you?” 
 
 “How did the breathing exercise and the DVD ex go in the last week?” 
 
 “How can we make your exercise experience better, if any?” 
 
 “This week, we will briefly talk about XXX from the little blue book you have got” 
 
Finished off by saying… 
 “I would encourage you to continue with the exercise regime as much as you feel comfortable 
with. Next week we will talk about XXX from the little blue book. I will catch up with you 
again next week!” 
 







Appendix N: 2017 Home-based pulmonary rehabilitation flowchart 





















Identified as suitable 
HBPR candidates through 
normal CBPR processes 
Melissa to do weekly phone 
contact (list of topics) + 
clinician input if needed 
Melissa or Admin
Melissa and David 
+Ask volunteer?
Melissa +/- Nurse 
+/- Volunteer
Melissa Melissa




assessemt, STST, CAT, 
HADS, EQ-5D), smoking 




Revisit exercises. Nurse 
review as needed
phone call to 
encourage and review 
exercises. Clinician 
input as needed.
repeat questionnaires, 
revisit exercise 
programme and 
introduce community 
exercise options
164 
 
 
